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ABSTRACT 
The brain network is a multiscale hierarchical organization from neurons and 
local circuits to macroscopic brain areas. The precise synaptic transmission at 
each synapse is therefore crucial for neural communication and the generation of 
orchestrated behaviors. Activation of presynaptic voltage-gated calcium channels 
(CaV2) initiates synaptic vesicle release and plays a key role in 
neurotransmission. In this dissertation, I have aimed to uncover how CaV2 
activity affects synaptic transmission, circuit function and behavioral outcomes 
using Caenorhabditis elegans as a model. The C. elegans genome encodes an 
ensemble of highly conserved neurotransmission machinery, providing an 
opportunity to study the molecular mechanisms of synaptic function in a powerful 
genetic system. I identified a novel gain of function CaV2α1 mutation that causes 
CaV2 channels to activate at a lower membrane potential and slow the 
inactivation. Cell-specific expression of these gain-of-function CaV2 channels is 
sufficient to hyper-activate neurons of interest, offering a way to study their roles 
in a given circuit. CaV2(gf) mutants display behavioral hyperactivity and an 
excitation-dominant synaptic transmission. Imbalanced excitation and inhibition 
of the nervous system have been associated with several neurological disorders, 
including Familial Hemiplegic Migraine type 1 (FHM1) which is caused by gain-
of-function mutations in the human CaV2.1α1 gene. I showed that animals 
carrying C. elegans CaV2α1 transgenes with corresponding human FHM1 
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mutations recapitulate the hyperactive behavioral phenotype exhibited by 
CaV2(gf) mutants, strongly suggesting the molecular function of CaV2 channels is 
highly conserved from C. elegans to human. Through performing a genome-wide 
forward genetic screen looking for CaV2α(gf) suppressors, we isolated new 
alleles of genes that required for CaV2 trafficking, localization and function. These 
regulators include subunits of CaV2 channel complex, components of synaptic 
and dense core vesicle release machinery as well as predicted extracellular 
proteins. Taken together, this work advances the understanding of CaV2 
malfunction at both cellular and circuit levels, and provides a genetically 
amenable model for neurological disorders associated with excitation-inhibition 
imbalance. Additionally, through identifying regulators of CaV2, this research 
provides new avenues for understanding the CaV2 channel mediated 
neurotransmission and potential pharmacological targets for the treatments of 
calcium channelopathies. 
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CHAPTER I 
 
 
 
 
Introduction  
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!
The brain network is a multiscale hierarchical organization from neurons, local 
circuits to macroscopic brain areas. Individual neurons are wired into neural 
circuits to perform specific functional outputs in response to environmental 
stimuli. The anatomical structure of the circuits and the precise 
neurotransmission at each synapse are therefore crucial for information 
processing in the brain network.  Synapses are specialized structures where 
neurons communicate with each other through neurotransmitters. The key 
component that defines a synapse is the active zone, which is a small, electron 
dense region located in the plasma membrane of the presynaptic terminal. An 
active zone contains a large core protein complex: RIM (Rab3-interacting 
molecules), RIM-BP (RIM biding proteins) and Munc13; as well as the 
components for synaptic vesicle fusion and exocytosis: SNARE and Munc18. 
This core protein complex docks and primes synaptic vesicles at the active zone 
and recruits the presynaptic voltage-gated calcium channel (VGCC) to the 
vesicle release sites (Südhof, 2012). When an action potential arrives, 
depolarization of the nerve terminal activates VGCCs. Neurotransmitters, which 
are packed into synaptic vesicles, are then released by calcium-dependent 
synaptic vesicle exocytosis into the synaptic cleft, where they bind postsynaptic 
receptors and trigger signaling cascades in postsynaptic neurons. During this 
process, the presynaptic VGCCs are necessary and crucial for converting the 
electrical signal of the action potential into released chemical signal across the 
synaptic cleft. 
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Voltage-gated calcium channels  
VGCCs activate upon membrane depolarization and mediate Ca2+ influx, 
which initiate many physiological events in different cell types. In cardiac and 
muscle cells, opening of the VGCC initiates the excitation-contraction coupling 
process by activating the ryanodine receptors that release the intracellular Ca2+ 
from the sarcoplasmic reticulum (Bers, 2002; Catterall et al., 1991; Mikami et al., 
1989). In neurons and some endocrine cells, the activation of VGCCs leads to 
the release of synaptic vesicles and secretion of hormones respectively (Dunlap 
et al., 1995; Tsien et al., 1988; Yang and Berggren, 2006).  In addition, in many 
different cell types VGCC-mediated Ca2+ entry into cytoplasm is involved in the 
regulation of enzyme activity and gene expression (Flavell and Greenberg, 
2008).  Based on the voltage-dependent and pharmacological properties, 
VGCCs can be grouped into three major types: the high-voltage activated (HVA) 
channels: CaV1 family (CaV1.1- CaV1.4, mediate L-type currents) and CaV2 family 
(CaV2.1, mediates P/Q-type; CaV2.2, mediates N-type; and CaV2.3, mediates R- 
type currents), and the low-voltage-gated (LVA) channels: CaV3 family (CaV3.1- 
CaV3.3, mediate T-type currents) (Table I-1) (Catterall 2011). In this chapter, I will 
focus on the structure and regulation of CaV2 channels that are exclusively 
expressed in neurons.  
 CaV2 channels, which structurally similar to CaV1 channels, are 
heteromultimeric protein complexes composed of a pore-forming CaVα1 subunit 
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(~ 190 kDa), plus two essential auxiliary subunits: CaVβ (~ 55 kDa) and CaVα2δ 
(~ 170 kDa) subunits (Liu et al., 1996; Witcher et al., 1993) (Figure I-1a). In some 
mammalian cell types, there is one extra auxiliary CaVγ subunit (Klugbauer et al., 
2000; Takahashi et al., 1987). The 3D structure of the CaV1 channel complex 
was solved for the first time in 2015 by single-particle cryo–electron microscopy 
(Wu et al., 2015, 2016). As previously predicted, the CaVα1 subunit is a 
transmembrane protein consisting of one single polypeptide chain that is 
organized into four repeated domains (TM I to IV) of six transmembrane helices 
(S1 to S6) (Figure I-1b). In each domain, the S4 segment functions as the 
voltage-sensing helix, while the S5 and S6 helices constitute the pore helices. 
The CaVα1 subunit therefore is the key determinant of the CaV2 channel kinetics 
and is also the target for most second-messenger modulation and 
pharmacological agents. The cytosolic CaVβ subunit binds the CaVα1 subunit 
through the α1 interaction domain (AID), which is localized in the first intracellular 
loop between domain I and II of the CaVα1 subunit (Chen et al., 2004; Opatowsky 
et al., 2004; Van Petegem et al., 2004). CaVβ subunits have been shown to 
facilitate trafficking of the CaVα1 subunit from endoplasmic reticulum (ER) to the 
membrane surface (Bichet et al., 2000) as well as modulate the voltage-
dependent activation/inactivation threshold of VGCCs (Buraei and Yang, 2010; 
He et al., 2007a). The CaVα2 subunit is an extracellular, extrinsic membrane 
protein attached to the membrane through disulfide linkage to the 
transmembrane CaVδ subunit (Gurnett et al., 1996). Because the CaVα2 and 
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CaVδ subunits are encoded by the same gene and are produced by post-
translational proteolytic processing and then disulfide-bonded, they are usually 
referred as the CaVα2δ subunits (De Jongh et al., 1990). CaVα2δ subunits 
interact with the CaVα1 subunit through extracellular loops of domain I to III in the 
CaVα1 subunit (Wu et al. 2015). ︎  CaVα2δ subunits are able to modify channel 
biophysical properties, but their main role is to increase calcium currents by 
promoting trafficking of the CaVα1 subunit to the plasma membrane and by 
increasing its retention there (Bernstein and Jones, 2007; Cantí et al., 2005; 
Davies et al., 2007).  
 
Regulation of the presynaptic CaV ︎ 2 channels 
Opening of CaV2 channels︎  results in Ca2+ influx from the extracellular 
space and gives rise to a localized elevation of intracellular Ca2+ concentration. 
This triggers a wide range of biophysical process from gene expression, synaptic 
transmission to the activation of various calcium-dependent enzymes, such as 
calmodulin-dependent protein kinase II (CaMKII) and protein kinase C (PKC) 
(Wadel et al., 2007; Wheeler et al., 2012). To precisely regulate these 
physiological events and prevent excitotoxity triggered by excess intracellular 
Ca2+  (Kass and Orrenius, 1999), the activity of CaV2 channels must be tightly 
regulated by both intrinsic gating and modulation by other interacting proteins.  
 
Calcium/Calmodulin-dependent inactivation and facilitation  
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Calcium-dependent inactivation and facilitation of CaV2 channels has been 
observed in the rat neurohypophysis as well as the calyx of Held synapse 
(Branchaw et al., 1997; Cuttle et al., 1998; Forsythe et al., 1998). A novel 
calmodulin binding site, calmodulin-binding domain (CBD), in the C-terminus of 
the CaV2α1 subunit was identified in mammalian cells expressing CaV2 channels 
(Lee et al. 1999). This calcium-dependent binding has multiple functions: it 
increases the rate and extent of voltage-dependent inactivation, enhances 
recovery from inactivation and augments further calcium influx by facilitating the 
calcium current. Electrophysiological recordings have shown that accumulation of 
intracellular calcium during a train of impulses would increase inactivation, 
shorten calcium transients and contribute to terminating the calcium signal 
following the train. Meanwhile, the binding of calmodulin also increases recovery 
from inactivation, thereby preparing the channels to respond more fully to a 
subsequent train of stimuli, and enhances that response by facilitation of the 
calcium current (Lee et al. 1999; Lee, Scheuer, and Catterall 2000). This dual 
feedback regulation of CaV2 channels provides an important mechanism for the 
activity-dependent synaptic plasticity.  
 
G-protein regulation 
 CaV2 channel-mediated currents are regulated through multiple G protein-
coupled pathways. While the G protein α subunits are thought to confer 
specificity in receptor coupling and activate a wide range of signaling pathways, 
! 7!
!
the G protein βγ subunits can directly interact with intracellular loop between 
domain I-II and the N-terminal region of the CaV2α1 subunits (Herlitze et al., 
1996; Ikeda, 1996; De Waard et al., 1997; Zamponi et al., 1997).  This interaction 
results in an inhibitory effect on CaV2 channel activity, stabilizing the closed 
conformation of the CaV2 channel, causing a positive shift in the voltage 
dependence and slowing activation (Bean, 1989). This Gβγ subunit mediated 
inhibition can be suppressed by application of large voltage pulses or by a series 
of short membrane depolarizations, and is therefore termed voltage-dependent 
inhibition. The strong depolarization causes a temporary dissociation of Gβγ 
subunits from the channel, thus briefly reverting the channel back to non-
modulated state (Bean, 1989).  
In addition to Gβγ subunit mediated inhibition, it is becoming increasingly 
clear that the CaV2 channels form signaling complexes (through direct or indirect 
interactions) with a range of different types of G-protein coupled receptors 
(GPCR), for instance: mGluR1, opioid receptor family and dopamine receptors 
(Evans et al., 2010; Kisilevsky et al., 2008; Kitano et al., 2003). Such channel-
GPCR signaling complexes have several potential functions: 1) optimize the 
efficiency of coupling between the receptor and the channels, 2) allow for 
agonist-dependent internalization of channel-GPCR complexes as a means of 
acutely controlling channel density in the plasma membrane via receptor 
activation (Altier et al., 2006; Kisilevsky et al., 2008). Together, the voltage-
dependent Gβγ subunit mediated inhibition along with channel-GPCR complexes 
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are critical for controlling the calcium entry through CaV2 channels (Huang and 
Zamponi, 2017).  
 
CaVβ subunit regulation 
Auxiliary CaVβ subunits interact with the CaVα1 subunits in a 1:1 
stoichiometry and reversible interaction (Tareilus et al., 1997) via the alpha 
interaction domain (AID) in the intracellular loop I-II of CaVα1 subunits (Chen et 
al., 2004). It has been well established that this interaction is required for 
membrane expression of CaVα1 subunits, both in heterologous expression 
systems and in vivo. The increased surface expression of VGCCs can be 
detected by surface staining, gating charge measurement and calcium currents 
(Gregg et al., 1996; Josephson and Varadi, 1996; Kamp et al., 1996; Obermair et 
al., 2010). Two possible mechanisms explain how the CaVβ subunit enhances 
the VGCC surface expression: 1) Binding of the CaVβ subunit masks the 
endoplasmic reticulum (ER) retention signal in the CaVα1 subunit, which 
facilitates CaVα1 subunits trafficking from the ER to plasma membrane (Bichet et 
al., 2000). 2) This interaction prevents the ubiquitination and proteasomal 
degradation of CaVα1 subunits (Altier et al., 2011).  
After the VGCC complex reaches the membrane, CaVβ subunits, except 
for one isoform, CaVβ2a, modulate the channel gating enhancing both the 
voltage-dependent activation (VDA) and voltage-gated inactivation (VDI) (Cahill 
et al., 2000; He et al., 2007a). Structural, biochemical and functional studies have 
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revealed a model for this modulation. Through the interaction with the CaVβ 
subunit, the entire interacting region of the α1 subunit (including the S6 of TM I 
and the intracellular loop between TM I and II) becoming a continuous α-helix. 
This conformational change likely affects the voltage-dependent movement of the 
pore gate (cytoplasmic region of S5 to S6 in each TM), thereby changing the 
voltage dependence and kinetics of the activation and inactivation (Buraei and 
Yang, 2010; Findeisen and Minor, 2009; Opatowsky et al., 2004).  
 
SNARE protein interaction 
CaV2 channels are crucial mediators of depolarization-evoked fast 
synaptic transmission. To ensure the efficient coupling of calcium influx and 
vesicle release, CaV2 channels have to be localized within active zones and 
synchronize with the synaptic exocytosis machinery. The CaV2α1 subunit 
contains a synaptic protein interaction site (synprint) in the intracellular loop 
between TM I-II.  This synprint site directly interacts with the SNARE proteins in a 
calcium-dependent manner (Sheng et al. 1994; Sheng et al. 1996; Rettig et al. 
1997). In addition to the functional role of interaction between CaV2 channels and 
SNARE proteins in facilitating the synaptic transmission, this interaction also 
regulates CaV2 channel function by promoting voltage-dependent inactivation 
and Gβγ modulation (Bezprozvanny et al., 1995; Jarvis and Zamponi, 2001). It is 
interesting to note that some invertebrates and mammalian isoforms of the 
CaV2α1 subunit have no synprint site (Kaneko et al., 2002; Spafford et al., 2003). 
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These CaV2 channels are recruited to the synaptic vesicle release site through 
other active zone proteins, such as Mint-1, CASK, RIM and RIM-binding proteins 
(Graf et al., 2012; Kaeser et al., 2011; Spafford et al., 2003). These findings may 
reveal other potential regulatory mechanisms for CaV2 channels at active zones 
independent of the SNARE proteins.    
Altogether, the mechanisms mentioned in this section provide multiple 
layers of regulation for CaV2 channels to ensure the calcium entry, synaptic 
release and calcium-dependent signaling pathways are precisely and tightly 
controlled.   
 
CaV2 channel dysfunction: calcium channelopathies   
 Dysregulation of CaV2 channel function is associated with severe 
neurological disorders including ataxia, epilepsy, migraine and autism-spectrum 
disorders (Adams and Snutch, 2007; Ophoff et al., 1996; Pietrobon, 2010; 
Zhuchenko et al., 1997). Mutations in the human CACNA1A gene, encoding the 
P/Q α1 subunit (CaV2.1α1), have been associated with three neurological 
disorders: (1) Episodic ataxia type 2 (EA2), whose clinical features include the 
lack of voluntary coordination of muscle movements, headaches and epileptic 
seizures. (2) Spinocerebellar ataxia type 6 (SCA6), a late onset, cerebellar 
atrophy resulting in progressive gait ataxia, limb incoordination and dysarthria. 
(3) Familial hemiplegic migraine 1 (FHM1), a severe variant of migraine with aura 
that can co-occur with tonic-clonic seizures.  
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 EA2 is associated with a wide range of mutations throughout the 
CACNA1A gene and include missense mutations, nonsense-, and splice site 
mutations (Jen et al., 2004). SCA6 patients have a polyglutamine expansion 
(CAG) at the 3’ end of CACNA1A gene (Zhuchenko et al., 1997). FHM1 
mutations are primarily found near the voltage sensors and flanking domains of 
the CaV2α1 subunit (Pietrobon, 2007; Thomsen et al., 2007). Although these 
three autosomal dominant disorders are conventionally distinguished, they 
exhibit considerable overlap in clinical features. This is further complicated by the 
fact that even family members with identical mutations can suffer from different 
pathological features.   
The functional consequences of several CACNA1A mutations have been 
investigated using electrophysiology in Xenopus and mammalian expression 
systems. EA2 missense mutations appear to cause a reduction in CaV2.1 
mediated currents (Guida et al., 2001; Spacey et al., 2004). Heterozygous 
nonsense mutations also show reduction in current density, most likely due to a 
dominant negative effect that results in fewer channels being properly folded and 
reaching the membrane (Jeng et al., 2008; Mezghrani et al., 2008). Thus EA2 
mutations seem to lead to reduced channel function, likely resulting in decreased 
neurotransmitter release (Jen et al., 2001). Studies from different heterologous 
expression systems and transfected neurons revealed that FHM1 mutations alter 
the CaV2.1 channel function in a much more complex way. Both gain- and 
reduction-of function phenotypes in channel function have been reported (Barrett 
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et al., 2005; Hans et al., 1999a; Tottene et al., 2002). In some cases, the different 
effects were dependent on the nature of the mutations; in other cases, the 
discrepancies may due to the specific isoform of the CaV2.1α1 subunit, as well as 
the CaVβ subunit it associates with.  
 
Study of CaV2 channels in Caenorhabditis elegans 
The nervous system of the Caenorhabditis elegans (C. elegans) adult 
hermaphrodite has only 302 neurons (Sulston and Horvitz 1977; White et al 
1986) yet is able to perform a wide range of behaviors, including chemotaxis, 
thermotaxis, escape behaviors in response to touch, mating, social feeding, and 
both associative and non-associative learning. In addition, C. elegans is the only 
organism that has the complete neural wiring diagram mapped out (White et al 
1986).  Along with the recent developments in using optogenetics and neural 
imaging in free behaving animals (Leifer et al., 2011; Venkatachalam et al., 
2016), C. elegans has become an increasingly important model to study 
neurobiological questions. 
The C. elegans genome encodes synaptic transmission machinery that is 
highly conserved to vertebrates. Genes involved in neurotransmitter 
biosynthesis, synaptic release mechanisms, and neurotransmitter receptors, as 
well as the ion channels and second messenger pathways are highly conserved 
(Bargmann, 1998). One of the great advantages of using C. elegans to study 
synaptic biology is that the genome often has a single recognizable member of a 
! 13!
!
gene family where vertebrates have three or four very similar genes. This 
provides an opportunity to study the functional consequences of eliminating 
individual synaptic proteins in a living organism without compensatory effect from 
other gene family members. Recently, techniques have also been developed to 
perform electrophysiological recording in C. elegans in vivo (Francis and Maricq, 
2006; Goodman et al., 2012). In addition, mutants that are defective in general 
synaptic transmission often exhibit pharmacological and behavioral phenotypes. 
This provides a valuable system to study the neural network, from genes and 
neurons to behaviors in vivo. These characteristics make C. elegans an attractive 
model organism to study synaptic function. 
C. elegans genome encodes a single CaVα1 subunit for each VGCC type: 
egl-19 (Raymond et al., 1997), unc-2 (Schafer and Kenyon, 1995) and cca-1 
(Steger et al., 2005) which appear to be orthologous to the CaV1(L-type), CaV2 
(N-, P/Q- and R-type ) and CaV3 (T-type). Genes that encode the auxiliary 
protein CaVα2δ (unc- 36) (Frøkjær-Jensen et al., 2006; Saheki and Bargmann, 
2009) and CaVβ subunit (ccb-1) have been identified as well (Lainé et al., 2011). 
CaV2α1/UNC-2 is exclusively expressed in neurons and localizes to presynaptic 
active zones (Saheki and Bargmann, 2009; Schafer and Kenyon, 1995). unc-2 
loss-of-function mutants are sluggish and uncoordinated and have defects in 
neurotransmitter release at the NMJ (Mathews et al., 2003; Richmond et al., 
2001), which further underlines the conserved and important role of the CaV2 
channels in synaptic transmission.   
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Thesis outline 
In this dissertation, I have aimed to uncover how CaV2 channel and its 
regulators affect synaptic transmission, circuit function and behavioral 
consequences using C. elegans as a model. In Chapter II, I will discuss a novel 
gain-of-function CaV2α1 mutation that causes CaV2 channel activation at a lower 
membrane potential with higher current density. The CaV2α1(gf) mutants display 
behavioral hyperactivity and excitation-dominant synaptic transmission. 
Elucidation of the underlying mechanisms of this imbalanced excitation and 
inhibition of the nervous system will potentially shed light on the pathology of 
human Familial Hemiplegic Migraine type 1 (FHM1), a calcium channelopathy 
resulted from increased CaV2 channel function. Chapter III describes a genome-
wide forward genetic screen for CaV2α1(gf) suppressors. New alleles of genes 
that functionally interact with CaV2 channels and regulate its function in synaptic 
transmission were identified from this screen.  
This thesis work provides a comprehensive understanding of Cav2 
channel regulation in vivo, insights into the etiology of calcium channelopathies, 
and new avenues of discovering promising targets for the treatment of related 
neurological disorders.  
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Figure I-1. Subunits and structure of CaV2 channels (a) Calcium channel 
heteromeric complex: the pore-forming subunit, CaVα1, and two auxiliary 
subunits, CaVβ and CaVα2δ. (b) The CaV2α1 subunit is comprised of four major 
transmembrane domains (TM I-IV), which are connected by cytoplasmic linkers. 
Each domain contains six membrane-spanning α-helices with a re-entrant pore 
loop (shown in green), and the fourth transmembrane segment contains 
positively charged amino acids and forms the voltage sensor.   
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Voltage 
Dependence 
 
 
Ca2+ Current  
Type 
 
CaV Channel 
Type 
 
Expression and Physiological 
functions 
HVA L-type CaV1.1 Skeletal muscles 
Excitation-contraction coupling; 
regulation of transcription 
  
 
 
CaV1.2 Cardiac muscles; Endocrine 
cells; Neurons 
Excitation-contraction coupling in 
cardiac and smooth muscle; 
endocrine secretion; Ca2+ 
transients in cell bodies and 
dendrites; regulation of 
transcription 
  CaV1.3 Endocrine cells; Neurons 
Endocrine secretion; cardiac 
pacemaking, Ca2+ transients in 
cell bodies and dendrites; auditory 
transduction  
 
  CaV1.4 Retina 
Visual transduction  
 
 P/Q-type CaV2.1 Neurons 
Neurotransmitter release; 
Dendritic Ca2+ transients 
 N-type CaV2.2 Neurons 
Neurotransmitter release; 
Dendritic Ca2+ transients 
 R-type CaV2.3 Neurons 
Neurotransmitter release; 
Dendritic Ca2+ transients 
LVA T-type CaV3.1 Skeletal and cardiac muscles; 
Neurons 
Pacemaking and repetitive firing  
 
 
 
 CaV3.2 Cardiac muscles; Neurons 
Pacemaking and repetitive firing  
 
  CaV3.3 Neurons 
Pacemaking and repetitive firing  
 
 
Table I-1 Voltage-gated calcium channel subtypes  
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CHAPTER II 
 
 
 
 
Behavioral and Functional Consequences of a Gain of Function  
Neuronal Voltage Gated Calcium Channel 
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Introduction 
Presynaptic CaV2 channels are one of the most abundantly expressed calcium 
channel subtypes in the mammalian nervous system. They mediate 
depolarization-induced calcium influx, which is essential for triggering synaptic 
vesicle release, and thus act as transducers of electrical signals into chemical 
signals. The major CaV2α1 subunit contains both the voltage-sensing mechanism 
and the calcium- selective pore, and largely determines the properties and 
kinetics of these channels. Mutations in the CACNA1A gene encoding the human 
CaV2.1α1 subunit have been associated with three neurological disorders: 
Episodic ataxia type 2 (EA2), Spinocerebellar ataxia type 6 (SCA6) and Familial 
hemiplegic migraine 1(FHM1) (Pietrobon, 2010). While missense and nonsense 
mutations attributed to EA2 appear to cause a reduction in CaV2 channel 
mediated currents, both gain- and loss-of function phenotypes in channel 
function have been reported for FHM1 mutations in different expression systems. 
Reported effects of FHM1 mutations on channel function can vary considerably 
leaving a precise correlation of genotype to phenotype unresolved.  
 The unc-2 gene encodes the sole CaV2α1 subunit in C.elegans. UNC-2 is 
exclusively expressed in neurons and localizes to presynaptic active zones ( 
Schafer and Kenyon 1995; Saheki and Bargmann 2009). unc-2 loss-of-function 
mutants have severe behavioral defects in locomotion, egg-laying and 
defecation, as well as deficits in neurotransmitter release at the NMJ (Mathews et 
al. 2003; Schafer and Kenyon 1995; Richmond, Weimer, and Jorgensen 2001). 
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These phenotypic defects are shared with animals harboring mutations in the 
Cav2 accessory subunit CaVα2δ/UNC-36, indicating a conserved role for 
CaV2α1/UNC-2 and its auxiliary proteins as a presynaptic regulator of synaptic 
transmission.  
In this study, we characterized a novel unc-2(gf) mutant which, contrary to 
loss of function mutations, displays hyperactive behaviors in locomotion and egg-
laying. We show that a G to R substitution in the highly conserved intracellular 
linker leads to a shift in the voltage dependence to more hyperpolarized 
potentials and reduces inactivation, suggesting a gain-of-function mutation. Cell 
specific expression of the UNC-2 gain-of-function channels is sufficient to 
increase synaptic transmission in neurons of interest. Transgenic animals 
carrying the unc-2 gene with human FHM1 mutations recapitulate the 
hyperactive behavioral phenotype. In addition, we showed that unc-2(gf) mutants 
have an excitation-dominant synaptic transmission at the NMJ, and this 
enhanced excitatory neurotransmission is dependent on muscle acetylcholine 
receptors. Imbalanced cortical excitation and inhibition have also been 
associated with FHM1 patients (Vecchia and Pietrobon, 2012). Therefore, we 
believe unc-2(gf) mutants may provide new insights into the pivotal role of Cav2 
channels in the integration of circuit activity.  
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Results 
zf35 mutants are hyperactive 
C. elegans locomotion is biased towards forward movement, interrupted 
by periodic brief reversals. From a forward genetic screen for animals with 
locomotion defects, we isolated a mutant, zf35, which displayed a dramatic 
increase in the number of spontaneous reversals (43.1 ± 2.0/ 3 min, n=59) 
compared to wild-type animals (6.8 ± 0.4/ 3 min, n=59) (Figure II-1a and c). This 
seizure-like phenotype of zf35 mutants is accompanied with an increased 
locomotion rate during bouts of forward or backward locomotion. On average 
about zf35 mutants move 1.5 fold faster than wild-type animals in either direction 
(Figure II-1a and b). Animals that were heterozygous for zf35 mutation also 
displayed an increased reversal and locomotion rate albeit to a lesser extent 
compared to homozygous mutants, indicating the zf35 mutation is semi-dominant 
(Figure II-1a-c). 
zf35 mutant animals had a reduced brood size (zf35: 150 ± 16, n=5, wild-
type: 207 ± 11, n=5) and were slightly smaller than wild-type animals. 
Furthermore, zf35 mutant animals often had a protruding vulva, indicative of 
hyperactive egg-laying behavior (Figure II-1d). To study egg- laying behavior we 
compared the egg laying rate of zf35 mutant and wild-type animals. zf35 animals 
retained a reduced number of eggs in the uterus (3.6 ± 0.2, n =86) compared to 
the wild-type (14.1 ± 0.6, n=80). Furthermore, zf35 mutants laid their eggs at an 
earlier developmental stage than the wild-type (Figure II-1e), showing that the 
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time between fertilization and egg laying was reduced in zf35 mutants. This 
indicates zf35 mutants are hyperactive in both locomotion and egg-laying 
behavior. 
 
The zf35 allele is a missense mutation in the CaV2α1/unc-2 gene  
We mapped the zf35 mutation to the left end of chromosome X between 
the genetic markers lon-2 and dpy-3. This region contains the gene, unc-2, which 
encodes the α1 subunit of the C. elegans CaV2 channel. Sequence analysis 
revealed that zf35 allele is a single-base transition (GGA -> AGA) in the 17th 
exon of unc-2 (Figure II-2a). The CaV2α1/UNC- 2 consists of four homologous 
transmembrane domains (TMI-IV) each containing six hydrophobic membrane-
spanning segments (S1–S6). The zf35 mutation results in a glycine to arginine 
substitution (G1132R) in the highly conserved intracellular linker between TM III-
S6 and TM IV- S1 (Figure II-2b and c). To determine if the zf35 mutation is 
sufficient to confer the hyperactive phenotype we generated an unc-2(zf35) 
cDNA clone, which encodes the CaV2α1/UNC-2(G1132R) protein. Pan-neuronal 
expression of the unc-2(zf35) transgene induced hyperactive behavior similar to 
that of the zf35 mutant in both wild-type and loss-of-function unc-2(e55) 
background. On the other hand, transgenic expression of the wild type unc-2 
transgene did not induce hyperactive behavior but did rescue the uncoordinated 
and lethargic phenotype of unc-2(e55) mutants (Figure II-3a), suggesting the 
zf35 mutation in the UNC-2 confers the behavioral hyperactivity. 
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unc-2(zf35) mutants did not display obvious defects in neural and axonal 
morphology. The wild type CaV2α1/UNC-2 localizes to presynaptic zones, at sites 
of synaptic vesicle secretion (Saheki and Bargmann, 2009). To determine if the 
zf35gf mutation affected localization to presynaptic sites, we looked the 
subcellular localization of the UNC-2(zf35) in transgenic animals carrying GFP 
tagged unc-2(zf35) cDNA. UNC-2(wt)::GFP was present in the cell body and 
localizes to puncta in the nerve ring and the ventral nerve cord (Saheki and 
Bargmann, 2009). The fluorescence expression pattern of UNC-2(zf35)::GFP 
animals displayed no obvious difference with that of animals that express a UNC-
2(wt)::GFP transgene (Figure II-3c), indicating that UNC-2(zf35) is properly 
processed and trafficked to presynaptic sites.  
 
Identification of intragenic unc-2(zf35) loss-of-function suppressors  
The sharp contrast between the unc-2(zf35) and unc-2(lf) mutant 
phenotypes suggests that the zf35 G1132R mutation is a rare gain-of-function 
mutation. Therefore, we sought to isolate intragenic mutations that suppress the 
hyperactivity phenotype of unc-2(zf35) mutants. From a screen of 10,000 haploid 
genomes we isolated 34 suppressors. SNP mapping and complementation tests 
identified 7 intragenic suppressor alleles of unc-2 (Figure II-2b). Four mutations, 
zf109, zf113, zf115 and zf124 caused severe locomotion defects similar to the 
canonical loss-of-function unc-2(e55) allele (Figure II-3b). Sequence analysis of 
the unc-2 gene of these mutants showed that two mutations, zf113(W551stop) 
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and zf124(M1371stop), result in a premature stop codons and therefore likely 
represent null alleles. zf115(C324Y) and zf109(L1357F) were found to be 
missense mutations that result in substitutions of highly conserved amino acids in 
the S5-S6 loop of domain I and IV, respectively. The S5-S6 loop forms re-entrant 
pore loop that is important in gating. Mutations in these loops are thus likely to 
impair CaV2 channel function.  While these nonsense and missense mutations 
result in severe uncoordinated locomotion phenotypes, the intragenic zf130 and 
zf134 suppressors caused moderate movement defects. The zf134(I970T) 
mutation results in a change an isoleucine to tyrosine domain in the conserved 
voltage sensor and the zf130(G1457D) mutation is predicted to result in a glycine 
to aspartate to the C-terminus in between a conserved EF-hand and the IQ like 
motif. The intragenic suppressor zf114(D892N) restored wild-type behavior in the 
unc-2(zf35) mutant background. The zf114(D892N) mutation is predicted to 
change an aspartate to asparagine domain III S2. The change from a negatively 
charged group to a polar, uncharged group may have specific interaction with the 
zf35 mutation without generally weaken the CaV2 channel function. These 
intragenic suppressors suppress unc-2(zf35) phenotype and largely recapitulate 
unc-2 loss-of-function phenotype. This strongly supports the notion that the unc-
2(zf35) mutation is a gain-of-function allele of unc-2. 
 
Cell-specific expression of the unc-2(zf35gf) transgene  
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Our data showed that gain-of-function CaV2α/UNC-2 channel leads 
behavioral hyperactivity in several aspects. Is cell-specific expression of the unc-
2(zf35gf) transgene sufficient to hyperactivate individual neurons? To address 
this question we expressed the unc-2(zf35gf) transgene in specific subsets of 
neurons and analyzed their effect on behaviors. The hermaphrodite specific 
motor neurons (HSNs) play a critical role in the regulation of the C. elegans egg-
laying program (Trent et al., 1983). HSNs make extensive neuromuscular 
junctions with the vulval muscles, and also direct synaptic output to other egg-
laying promoting motor neurons, VCs (Schafer 2005) (Figure II-4a and b). 
Transgenic animals that expresses the unc-2(zf35gf) transgene specifically in the 
HSNs have fewer eggs in their uterus and lay eggs at earlier developmental 
stage compared to the wild-type (Figure II-4c and d). These results suggest we 
are able to promote egg-laying by expressing unc-2(zf35gf) transgene in HSNs, 
and this effect is most likely due to the increased release of serotonin.  
In C. elegans, directional movements is controlled by a set of pre-motor 
interneurons: the AVB and PVC neurons control forward movement while the 
AVA, AVD and AVE neurons drive backing (Chalfie et al. 1985) (Figure II-4a and 
b). We therefore expressed the unc-2(zf35gf) transgene in subsets of pre-motor 
interneurons to determine whether they could recapitulate the hyper reversal 
phenotype of unc-2(zf35gf) mutants. Transgenic animals that express the unc-
2(zf35gf) transgene in the PVC, AVA, AVD and AVE pre-motor interneurons 
exhibited a marked increase in reversal frequency. Expression of the unc-
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2(zf35gf) transgene in the AVA backward premotor interneuron resulted in a 
milder but significant increase reversal frequency, while expression in the AVB 
neurons or cholinergic motor neurons had no appreciable effect on the reversal 
frequency (Figure II-4e). This indicates that the expression of the unc-2(zf35gf) 
transgene in pre- motor interneurons that drive backward locomotion increases 
the reversal rate. Transgenic animals that express the unc-2(zf35gf) transgene in 
pre-motor interneurons did not display apparent behavioral defects in the 
locomotion rate or egg laying. Furthermore, cell-specific expression of the unc-
2(zf35gf) transgene in cholinergic motor neurons that have synaptic connection 
onto body wall muscles markedly increased the sensitivity to the aldicarb, while 
animals that carry unc-2(zf35gf) transgene GABAergic neurons were resistant 
the adlicarb (Figure II-4f). Taken together, our data suggests that cell specific 
expression of unc-2(zf35gf) transgene is sufficient to increase excitability of 
specific neural subsets.  
The characteristic sinusoidal movement of C. elegans is regulated by 
motor neurons in the ventral nerve cord, which alternate contraction and 
relaxation of the dorsal and ventral longitudinal muscle rows. When one side of 
the body wall muscles is activated, the contralateral side is inhibited. Animals that 
expresses the optogenetic protein, Channelrhodopsin-2 (ChR2), in either 
cholinergic or GABAergic motor neurons cease their locomotion when these 
subsets of neurons are activated by light. To dissect the role of cholinergic and 
GABAergic motor neurons in both generation and propagation of the sinusoidal 
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movement, we expressed the unc-2(zf35gf) transgene specifically in either class 
of the motor neurons. We observed that animals with increased cholinergic motor 
neuron activity have elevated body bend amplitude as well as head motion angle 
(Figure II-4g and h). By contrast, increased GABAergic motor neuron activity 
inhibits the head motion angle but does not alter the body bend amplitude (Figure 
II-4g and h). This decreased head motion is likely due to increased GABA 
released from the RMEs (Shen et al., 2016). Our data suggests that cell specific 
expression of unc-2(zf35gf) transgene not only allows us to hyperactivate specific 
neuron subsets but also to study theirs roles within a given neural circuit in its 
native context.  
 
The biophysical consequences of the zf35 mutation  
To investigate the functional consequences of the CaV2α1/UNC-2(ZF35) 
mutation, we introduced the human corresponding change, G1518R into the 
human P/Q type CaV2.1 channel α1 subunit CACNA1A. CaV2.1α1 expression 
constructs were transfected it in a stable HEK 293 cell line that expresses the 
auxiliary CaVβ1c and CaVα2δ subunits (Piedras-Renteria et al., 2001). We 
performed whole cell patch clamp experiments to determine the channel kinetics 
for the wild type and G1518R channel (Figure II-5a and b). The current-voltage 
relationships of the G1518R CaV2.1 channel shifted for about 10 mV to more 
negative potentials compared to the wild-type CaV2.1 channel (Figure II-5c). 
Furthermore, the maximal current density was 1.7-fold larger for the G1518R 
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CaV2.1 channels (80.6 ± 5.7 pA/pF, n=11) compared to the wild type (47.5 ± 4.3 
pA/pF, n=13). The slope of the activation curve was not significantly affected in 
the G1518R CaV2.1 channels (Ka wt= 3.8 ± 0.2 mV; Ka G1518R= 4.1 ± 0.1 mV, 
Figure II-5c).  
Currents of both wild-type and G1518R CaV2.1 channels decayed with 
similar mono-exponential time courses (τinac wt = 177 ± 45 ms and τinac G1518R = 
196 ± 32 ms at a 0 mV pulse). This suggested that the transition from the open to 
the inactive states was not affected by the G1518R mutation. To determine if 
inactivation following closed states were altered we compared steady-state 
inactivation properties of the wild-type and G1518R CaV2.1 channel (Figure II-
5d). The membrane potential at which half of the current was inactivated in the 
G1518R CaV2.1 channels was 7.7 mV more positive compared to the wild type 
(V0.5inact= -55.0 ± 1.0 mV for wild-type channels and V0.5inact = -47.3 ± 1.0 mV for 
G1518R CaV2.1 channels). The displacement to more depolarized membrane 
potentials indicates that the proportion of activatable channels at a given 
membrane potential is increased in G1518R CaV2.1 channels.  
Thus, the G1518R mutation in the intracellular linker between TM III and 
TM IV changes the voltage sensitivity, causing channels to activate at lower 
membrane potentials and inactivate at higher membrane potentials. Together 
with the increase in current density, these kinetic properties of the G1518R 
CaV2.1 channels may lead to elevated synaptic release. The high level of 
conservation in the TM III-IV linker between C. elegans and human strongly 
! 28!
!
suggest that the corresponding G1132R mutation in C. elegans CaV2α1/UNC-2 
channel would lead to similar gain-of-function effects in activation and 
inactivation kinetics.   
 
Transgenic animals carrying FHM1 CaV2α1 mutations recapitulate the unc-
2(zf35gf) mutant hyperactive phenotype  
Mutations in the human CACANA1A gene can result in Familial 
Hemiplegic Migraine type 1 (FHM1) (Pietrobon, 2010). Electrophysiological 
analysis of the effects of several FHM1 mutations on CaV2.1 channel function 
have been shown to increase current density or shift the voltage dependence of 
activation to more hyperpolarized potentials (Hans et al., 1999a; Kraus et al., 
1998; Van Den Maagdenberg et al., 2004). To determine if FHM1 mutations 
cause similar behavioral effects in C. elegans as the unc-2(zf35gf) mutation, we 
introduced two well-characterized human FHM1 mutations, R192Q and S218L, 
into the unc-2 gene (Figure II-6a). Pan-neuronal expression of the unc-
2(FHM1R192Q) or unc-2(FHM1S218L) transgene resulted in an increased 
reversal frequency (25.5 ± 0.9, n=34 and 16.5 ± 0.9, n=33, respectively) 
compared to the wild-type (4.2 ± 0.5, n=29) (Figure II-6b). Furthermore, the unc- 
2(FHM1R192Q) or unc-2(FHM1S218L) transgenic animals displayed hyperactive 
egg-laying behavior similar to unc-2(zf35gf) mutants (Figure II-6c). unc-
2(FHM1R192Q) or unc-2(FHM1S218L) transgenic animals retained fewer eggs 
in the uterus (5.7 ± 0.4, n=37 and 8.4 ± 0.6, n=32, respectively) than the wild type 
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(16.5 ± 0.8, n=23), and laid eggs at an earlier developmental stage. Both FHM1 
R192Q or S218L mutations in the unc-2 gene recapitulated unc-2(zf35gf) 
hyperactive behavioral phenotypes, providing clear genetic evidence that the 
FHM1 mutations are gain-of-function mutations.  
 
Elevated reversal frequency in unc-2(zf35gf) mutants is glutamate signaling 
dependent  
Why do CaV2α1/unc-2(zf35gf) mutants have an increased reversal 
frequency? Five pairs of interneurons (backward locomotion: AVA, AVD, AVE, 
and forward locomotion: AVB, PVC) are required for the control of directional 
movement in C.elegans (Chalfie et al. 1985). These pre-motor interneurons 
make reciprocal electrical and chemical synaptic contacts which mediate a 
bistable switch for forward and backward movement (Chalfie et al., 1985; Wicks 
and Rankin, 1995). glr-1, a gene encoding a non-NMDA glutamate receptor 
subtype, is expressed exclusively in this subset of neurons (Maricq et al., 1995). 
Interestingly, transgenic animals carrying a gain-of-function mutation in GLR-1 
receptor display a rapid alternation between forward and backward movement 
similar to CaV2α1/unc-2(zf35gf) mutants, and the increased reversal rate is 
mediated by elevated depolarization frequency of the interneurons (Zheng et al., 
1999). We therefore determined whether glutamate signaling is required for the 
hyper reversal phenotype of unc-2(zf35gf) mutants by analyzing locomotion 
behavior of unc-2(zf35gf) double mutants with glr-1 and eat-4  which encodes the 
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vesicular glutamate transporter. The hyperrevesal phenotype of unc-2(zf35gf) 
mutants  (31.2 ± 1.4 reversals, n=10) was largely suppressed in glr-1;unc-
2(zf35gf) mutants (11.59 ± 0.8 reversals, n=27)  and eat-4; unc-2(zf35gf) double 
mutants (6.18 ± 0.9 reversals, n=22) (Figure II-7), underlining the importance of 
glutamate-mediated signaling in regulating directional movement. Our results 
suggest that the increased reversal frequency in CaV2α1/unc-2(zf35gf) mutants 
may be due to an elevated glutamate release from glutamatergic sensory 
neurons onto pre-motor interneurons that control directional movement.  
 
CaV2α1/unc-2 gain-of-function mutations increase sensitivity to aldicarb  
  To determine the functional consequences of unc-2(zf35gf) mutation in 
synaptic transmission, we analyzed their sensitivity to the cholinesterase 
inhibitor, aldicarb. The C. elegans body wall muscles receive excitatory 
cholinergic inputs. Aldicarb treatment causes the accumulation of acetylcholine 
(ACh) at the neuromuscular junction inducing hyper contraction of body wall 
muscles and acute paralysis. When placed on agar plates containing 1mM 
aldicarb approximately 50% of the wild type animals paralyzed within an hour. 
Consistent with previous results (Mathews et al., 2003; Miller et al., 1996), less 
than 10% unc-2(lf) mutants paralyzed in this time frame. In sharp contrast, 100% 
unc-2(zf35gf) mutants paralyzed within 30 minutes on aldicarb plates (Figure II-
8a). All heterogyzous unc-2(zf35gf)/+ mutants paralyzed in approximately one 
hour, whereas it took about two hours for all wild-type animals to paralyze, 
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confirming that unc-2(zf35gf) mutation is semi-dominant. Pan-neuronal 
expression of the unc-2(zf35gf) transgene, unc-2(FHM1R192Q) or unc-
2(FHM1S218L) induced hypersensitivity to aldicarb. The hypersensitivity is not 
due to overexpression of the CaV2 channels since the unc-2(wt) transgene 
restored the locomotion defects in unc-2(lf) mutants and wild-type sensitivity to 
aldicarb (Figure II-8b). Our data indicate gain-of function mutations in 
CaV2α1/UNC-2 result in increased ACh release.  
 
unc-2(zf35gf) mutants have increased cholinergic and decreased 
GABAergic transmission. 
To directly assay the effect of the unc-2(zf35gf) mutation on synaptic 
function we recorded miniature postsynaptic currents (mPSCs) at the body wall 
muscle. mPSCs are spontaneous release events caused the fusion of a single or 
a few synaptic vesicles from motor neurons. mPSC recordings were performed at 
a holding potential of -60mV under conditions which both cholinergic and 
GABAergic mPSCs appear as inward currents (see Material and Methods). unc-
2(zf35gf) mutants show a striking two-fold increase in the frequency of total 
mPSCs compared to wild-type animals with no significant changes in the 
amplitude (Figure II-9a to c). Since excitatory and inhibitory neurotransmitter 
systems appear differentially affected in FHM1 mouse models (Tottene et al., 
2009), we analyzed the effect of unc-2(zf35gf) mutation on cholinergic and 
GABAergic transmission separately. To isolate ACh currents, recordings were 
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made in an unc-49 mutant background, which lacks inhibitory neurotransmission 
at the NMJ. The frequency of the endogenous excitatory postsynaptic currents 
(mEPSCs) is increased two-fold compared with the wild type (Figure II-9d to f). In 
contrast, the endogenous GABAergic postsynaptic currents (mIPSCs) showed a 
striking reduction in frequency (Figure II-9g to i). Thus, these experiments 
indicate unc-2(zf35gf) mutants shift the E/I balance towards excitatory 
transmission (McEwen et al., 2006; Vashlishan et al., 2008).  
 
unc-2(zf35gf) mutations affect the development of cholinergic and 
GABAergic synapses 
Changes in synaptic activity can modulate the distribution of synaptic 
proteins (Fauth and Tetzlaff, 2016; Turrigiano, 2012). To determine if the 
increased UNC-2 activity affects synaptic development, we examined the 
distribution and morphology of pre-synaptic and postsynaptic markers at the NMJ 
(Figure II-10a). Cholinergic synapses were labeled with the synaptic vesicle 
marker RAB-3::mCherry (Pacr-2:: RAB-3) and the nicotinic acetylcholine receptor 
subunits Punc-29::UNC-29::GFP as a post-synaptic markers (Figure II-10b).  
RAB-3::mCherry puncta were larger in unc-2(zf35gf) mutants compared to those 
in the wild-type background (Figure II-10b and c). This is consistent with the 
notion that increased calcium influx can recruit more synaptic vesicles to release 
sites. At the post synaptic sites we found a marked increase in the size of UNC-
29::GFP clusters, indicating an increase in the post-synaptic ACh receptors 
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(Figure II-10b and d). To pharmacologically test if the enhanced level of ACh 
receptor at synapses leads to functional consequences, we examined the 
response of unc-2(zf35gf) mutants to the ACh receptor agonist, levamisole. 
Levamisole directly binds to UNC-29 ACh receptors in body wall muscles and 
leads to hypercontracted paralysis (Barbagallo et al., 2010). unc-2(zf35gf) 
mutants were hypersensitive to levamisole induced paralysis, supporting an 
increased ACh receptor expression at the NMJ (Figure II-11a). These pre- and 
post-synaptic morphological changes and pharmacological responses indicate 
that CaV2α/unc-2 gain of function mutations strengthen excitatory cholinergic 
synapses.  
To gain insight into the mechanisms of reduced GABA signaling in unc-
2(zf35gf) mutants we visualized GABAergic synapses with the pre-synaptic 
vesicle marker RAB-3::mCherry (Punc-25:: RAB-3) and the GABA receptor UNC-
49::GFP (Punc-49::UNC-49::GFP) as a post-synaptic marker. unc-2(zf35gf) 
mutants displayed enhanced expression of the RAB-3::mCherry marker along the 
axons of GABAergic neurons (Figure II-10e and f), comparable to the increased 
expression of the presynaptic marker we observed in cholinergic motor neurons. 
However, in contrast to the increased expression of ACh receptors at the 
cholinergic synapse, UNC-49::GFP expression was strongly reduced and 
unevenly distributed in unc-2(zf35gf) mutants (Fig.II-10e and g).  
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To determine if changes in UNC-49::GFP fluorescence reflect functional 
alterations in endogenous receptors expression, we analyzed the behavioral 
response of unc-2(zf35gf) mutants to the GABA agonist, muscimol. Muscimol 
treatment of body-wall muscle cells leads to hyperpolarization by an inward Cl- 
flux that is dependent on the GABA receptor channel UNC-49 (Richmond and 
Jorgensen 1999). When touched on the head, wild-type animals treated with 
1mM muscimol display a rubberband phenotype in which the body wall muscles 
contract and then relax without moving backwards (de la Cruz et al., 2003). To 
quantify muscimol responses, animals were scored according to the presence of 
a contraction–relaxation cycle and backward movement into five categories from 
unaffected locomotion (0) to complete flaccid paralysis (4) (see Materials and 
Methods). On muscimol plates, most wild-type animals displayed flaccid 
paralysis or rubberband phenotype where the animal failed to move backward in 
response to touch. In contrast, most unc-2(zf35gf) mutants were able to move 
away from the touch stimulus (Figure II-11b). The partial resistance of unc-
2(zf35gf) mutants to muscimol-induced muscle relaxation is consistent with the 
reduction of UNC-49 expression at the NMJ and likely the cause of the 
decreased GABA neurotransmission.     
 
Increased cholinergic signaling in unc-2(zf35gf) mutants leads to the 
reduction of GABA receptor 
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 Why does a gain-function-mutation in the presynaptic CaV2 channel lead 
to a reduction in postsynaptic GABA receptor clustering at the NMJ? To test if 
unc-2(zf35gf) mediated increases neuronal excitability affect GABA receptor 
clustering, we analyzed UNC-49::GFP expression in acr-12; unc-2(zf35gf) double 
mutants. Mutations in the gene that encodes the cholinergic ACR-12 receptor, 
reduce excitability of cholinergic and GABAergic motor neurons (Jospin et al., 
2009; Petrash et al., 2013). We found that the loss of ACR-12 restored the GABA 
receptor clustering in unc-2(zf35gf) mutants (Figure II-12c and d). This raises the 
possibility that increased presynaptic calcium transients and transmitter release 
from GABAergic motor neurons results in compensatory down regulation of 
GABA receptors at the post synapse. We therefore analyzed UNC-49::GFP 
clustering in transgenic animals that specifically express unc-2(zf35gf) in 
GABAergic motor neurons. Animals carrying punc-47::unc-2(zf35gf) transgenes 
are partially resistant to aldicarb indicative of increased in GABAergic signaling 
onto the body wall muscles (data not shown). Surprisingly, specific expression of 
unc-2(zf35gf) in GABA motor neurons of resulted in increased UNC-49 
fluorescence at the NMJ (Figure II-12c and d). This suggests that the increased 
GABA signaling results in strengthening of GABAergic synapses; and the 
reduction of GABA receptor clustering in unc-2(zf35gf) mutants is not caused by 
elevated activity of GABAergic neurons.  
Could the reduction in GABA receptor expression in unc-2(zf35gf) be a 
secondary effect of the increased cholinergic signaling? Cholinergic activation of 
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GABAergic neurons has been shown to play a prominent role in the development 
of GABAergic outputs (Barbagello et al Development in press). Interestingly, 
hyperactivation of cholinergic motor neurons through a gain-of-function mutation 
in the acetylcholine receptor, ACR-2, leads to a strong reduction GABAergic 
signaling (Jospin et al., 2009). To test if cholinergic neurotransmission onto 
muscles affect the GABA receptor clustering, we genetically eliminated the 
postsynaptic acetylcholine receptor, UNC-29. Strikingly, the loss of UNC-29 
restored the GABA receptor clustering in unc-29;unc-2(zf35gf) animals (Figure II-
12c and d), This suggests the increased cholinergic depolarization affects the 
GABA receptor clustering on body wall muscles. 
   
Discussion 
Presynaptic voltage-gated calcium channels (CaV2) are crucial regulators of 
synaptic transmission. C. elegans has a single predicted neuronal CaV2α1 
subunit, encoded by the unc-2 gene (Bargmann, 1998). unc-2 loss of function 
mutants are lethargic and sluggish, a phenotype similar to mutants with synaptic 
transmission defects (Schafer and Kenyon 1995; Miller et al. 1996). Here we 
report the isolation of a novel gain-of- function mutation in the unc-2 gene. unc-
2(zf35gf) mutants are hyperactive in sharp contrast to unc-2(lf) mutants. zf35gf 
mutation results in a G to R substitution in a highly conserved region in the third 
intracellular linker between TM III and TM IV. Our electrophysiological analysis 
shows that this G to R substitution in the human CaV2.1 channel CACNA1A 
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causes a shift in the activation voltage to a more negative potentials and 
inactivation at higher potentials. These changes in channel properties are similar 
to those reported for several human FHM1 CaV2.1 channels (Hans et al., 1999a; 
Müllner et al., 2004; Tottene et al., 2005). While in heterologous expression 
system studies the effects on channel properties vary, most FHM1 mutations 
appear to lead to channel activation at lower voltages and increased channel 
open probability. The G1132R mutation increases calcium influx at lower 
membrane potentials, which would lead to an increase in neurotransmitter 
release probability. Interestingly, a similar G to R mutation in an intracellular 
linker of the human CaV1.2 channel results in defects in channel inactivation and 
is the underlying cause of Timothy syndrome, which is an autosomal 
dominant neurological disorder with heart QT-prolongation, heart arrhythmias, 
structural heart defects as well as autism spectrum disorders (Splawski et al., 
2004). The G1132R mutation may change the CaV2 channel function by directly 
affecting the electrophysiological properties of CaV2α1/UNC-2, the central pore of 
the channel. Intracellular linkers of CaV2 channels have also been implicated in 
the modulation of channel kinetics through phosphorylation regulation as well as 
associating with the intracellular effector proteins, such as CaVβ subunit, G 
protein βγ subunits and calmodulin (Zamponi and Snutch, 2002). Thus we cannot 
exclude that the G1132R mutation affects the interaction with cytoplasmic 
proteins that modulate channel function.  
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Intragenic suppressors of the unc-2(zf35gf) mutant resemble those found 
in EA2 patients and include premature stop codons and missense mutations. 
Interestingly, similar to our C324Y unc-2(zf35gf) suppressor, a cysteine to 
tyrosine substitution (C287Y) in the domain I S5-S6 loop of CACNA1A has been 
associated with human EA2 patients (Wan et al., 2005). Furthermore, amino acid 
substitutions in a highly conserved leucine in the domain IV S5-S6 loop are found 
in both human EA2 patients (L1749P) and our unc-2(zf35gf) suppressor 
(L1357F). Thus C. elegans can be an efficient model to determine the in vivo 
consequences of CaV2α1 subunit mutations. While truncated mutations in EA2 
show dominant-negative suppression (Jeng et al., 2008; Raike et al., 2007), unc-
2(zf35gf) intragenic suppressors are recessive. This is likely due to the much 
longer intracellular loop between domain I and II in human CACNA1A. This 
region has been shown to be required for the dominant-negative suppression 
through interacting with cytoplasmic proteins including the CaVβ subunits (Raike 
et al., 2007).  
Gain of function mutations in the CACNA1A gene, which encodes the 
human CaV2.1 α1 subunit, have been identified in patients with Familial 
Hemiplegic Migraine 1(FHM1) (Hans et al., 1999a; Tottene et al., 2005). Data 
from the FHM1 knock-in mice suggest that the gain-of-function 
CaV2.1/CACNA1A channels exhibit an increase in calcium influx and are 
activated at lower membrane potentials (Tottene et al., 2005), which are similar 
functional consequences to the zf35(G1132R) mutation in CaV2.1/CACNA1A 
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channels. Interestingly, transgenic animals that express corresponding FHM1 
mutations in unc-2 transgenes recapitulate the behavioral hyperactivity of unc-
2(zf35gf) mutants. Together with the patch clamp recoding from the human 
G1518R CaV2.1 channels, our results provide an important proof-of-principle that 
the molecular function of CaV2α1 is highly conserved from C. elegans UNC-2 
worms to human CACNA1A. Therefore the unc-2(zf35gf) mutant provides a 
powerful genetic handle to study the underlying molecular mechanisms of FHM1 
pathology.  
 unc-2(zf35gf) mutants are extremely sensitive to the acetylcholinesterase 
inhibitor aldicarb, and show a two-fold increase in frequency of the endogenous 
postsynaptic currents. This is in sharp contrast with unc-2 loss of function 
mutants, which are resistant to alidicarb (Miller et al., 1996) and have a 
significant reduction in endogenous postsynaptic currents (Richmond, Weimer, 
and Jorgensen 2001). This indicates that the shift to lower voltage of activation 
and a slow inactivation of the gain-of-function UNC-2 channel leads to a 
significant increase of synaptic transmission at the NMJ. Surprisingly, recordings 
from cholinergic and GABAergic synapses separately in unc-2(zf35gf) mutants 
showed the increased neurotransmission is specific to cholinergic synapses, and 
a significant reduction in GABA transmission was observed. We further show that 
this reduction is likely due to a decrease in GABA receptor expression at the 
postsynaptic domains and is dependent on the activation of muscle acetylcholine 
receptors. In cultured hippocampal neurons, enhanced excitatory synaptic 
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activity has been reported to decrease the cluster size of GABAARs and 
GABAergic neurotransmission through NMDA receptor-dependent calcium influx 
and calcineurin dephosphorylation (Bannai et al., 2009, 2015). These studies are 
consistent with our findings in C. elegans and suggest a potential conserved 
mechanism of GABA receptor regulation. We speculate that constitutively 
activation of nicotinic receptors leads to sustained depolarization of body wall 
muscles, which in turn activates CaV1 channels. The elevated calcium influx then 
triggers calcium-dependent signaling and causes the dispersion or internalization 
of the GABA receptor (Figure II-13). Imbalanced excitation-inhibition 
neurotransmission has been associated with FHM1 (Vecchia and Pietrobon, 
2012). Elucidation of underlying mechanisms of GABA receptor reduction in unc-
2(zf35gf) mutants may provide insight into FHM1 pathogenesis.   
In addition to analyzing behavioral and functional consequences of the 
unc-2(zf35gf) mutation, we showed that cell-specific expression of the unc-
2(zf35gf) transgene is sufficient to recapitulate hyperactive behaviors. Transgenic 
animals that express the unc-2(zf35gf) transgene in the backward locomotion 
interneurons exhibit an increased reversal frequency, while expression in the 
hermaphrodite specific neurons (HSN) produces hyperactive egg-laying. This 
suggests that the unc-2(zf35gf) transgene can be used as a tool to genetically 
hyper-activate specific neurons by increasing neurotransmitter release in 
neurons of interest. Instead of acutely depolarizing the neurons, maximizing the 
output from particular neurons, the unc-2(zf35gf) transgene presents a way to 
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sensitize the neurons and chronically increases synaptic release from the 
neurons. This offers an opportunity to modulate neurons and circuits in the 
context of their natural circuit activity, and study the effect of chronic hyperactivity 
on circuit development and function.  
 
 
Materials and Methods 
Strains  
All strains were cultured at room temperature (22-24 ̊C) on nematode growth 
media (NGM) agar plates with the E. coli strain OP50 as a food source 
Experiments were performed on young adult animals (24 hr post-L4 larva) at 
room temperature (22-24 ̊C). The wild-type strain was Bristol N2. Transgenic 
strains were obtained by microinjection of plasmid DNA into the germline with 
coinjection marker lin-15 rescuing plasmid pL15EK both at 80 ng/µl into unc-
2(e55); lin-15(n765ts) or lin15(n765ts) animals. At least three independent 
transgenic lines were obtained. The data presented are from a single 
representative line. The following strains were utilized in this study: 
CB55 unc-2 (e55)  
QW37 unc-2 (zf35gf) 
QW355 unc-2 (zf109)  
QW359 unc-2 (zf113)  
QW360 unc-2 (zf114)  
QW441 unc-2 (zf115)  
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QW720 unc-2 (zf124)  
QW726 unc-2 (zf130)  
QW849 unc-2 (zf134)  
QW388 unc-2(e55); zfex51[Ptag-168::unc-2(zf35gf)]  
QW392 unc-2(e55); zfex52[Ptag-168::unc-2]  
QW863 unc-2(e55); zfex327[ptag168::unc-2(FHM1 S218L)]; lin-15(n765ts)  
QW864 unc-2(lj1); zfex328[ptag168::unc-2(FHM1 R192Q)]; lin-15(n765ts)  
QW1317 unc-2(e55); zfex575[ptag168::unc-2::gfp]; lin-15(n765ts)  
QW1362 unc-2(e55); zfex601[ptag168::unc-2(zf35gf)::gfp]; lin-15(n765ts)  
QW714 zfex260[plgc-55s::unc-2(zf35gf)]; lin-15(n765ts)  
QW766 zfex286[prig-3::unc-2(zf35gf)]; lin-15(n765ts)  
QW732 zfex262[pnmr-1::unc-2(zf35gf)]; lin-15(n765ts)  
QW735 zfex265[pglr-1::unc-2(zf35gf)]; lin-15(n765ts)  
QW850 zfex324[ptph-1(HSN)::unc-2(zf35gf)]; lin-15(n765ts)  
QW547 zfex140[pacr-2::unc-2(zf35gf)]; lin-15(n765ts)  
Transgenic strains were obtained by microinjection of plasmid DNA into 
the germline with coinjection marker lin-15 rescuing plasmid pL15EK both at 80 
ng/µl into unc-2(e55); lin-15(n765ts) or lin15(n765ts) animals. At least three 
independent transgenic lines were obtained. The data presented are from a 
single representative line.  
 
Molecular Biology and plasmids  
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Full length unc-2(wt) and unc-2(zf35gf) rescuing clones were obtained from Y. 
Saheki and C. Bargmann. Briefly, the unc-2 cDNA was cloned behind the pan 
neuronal promoter, Ptag-168, using restriction sites AscI and XhoI to generate 
the Ptag-168::unc-2(wt) construct. The unc-2(zf35gf) mutation was introduced in 
the cDNA clone using site-directed mutagenesis. For cell-specific unc- 2(zf35gf) 
transgene expression, cell specific promoters Pnmr-1 44, Pglr-1 44, Prig-3 45, 
Plgc-55s 46, Ptph-1 32 and Pacr-2 47 were amplified by PCR with FseI 
sequences at 5’ end and AscI sequences at 3’ end. The Ptag-168::unc-2(zf35gf) 
construct was digested with FseI and AscI to remove the Ptag-168 promoter and 
replace with cell specific promoters of interest.  
 
Isolation of unc-2(zf35gf) mutants, Mapping and Cloning  
unc-2(zf35gf) allele was isolated in a screen for animals that were resistant to the 
immobilizing effects exogenous tyramine as previously described 46. We 
mapped unc-2(zf35) to LG X based on its hyperactive locomotion phenotype 
using SNP mapping 48,49. Three-factor mapping placed unc-2(zf35) to the left of 
lon-2 and close to dpy-3.  
 
Isolation and identification of intragenic unc-2(zf35gf) suppressors  
unc-2(zf35gf) L4 animals (P0) were mutagenized with 0.5 mM N-ethyl-N-
nitrosourea (ENU) for 4 hr. Approximately 10, 000 F1 animals were bleached to 
obtain F2 eggs. F2 eggs were plated on NGM plates containing 0.25 mM alicarb 
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and examined for viable progeny after 7 and 14 days. Aldicarb resistant animals 
were individually transferred to fresh NGM plates, and their progeny were 
retested for aldicarb resistance. All suppressors isolated from the screen were 
first backcrossed with wild-type N2. Suppressors that showed linkage to the X-
chromosome were tested for complementation with unc-2(lf) mutants. Molecular 
changes in unc-2 intragenic suppressors were identified by DNA sequencing of 
the unc-2 gene.  
 
Behavioral and pharmacological assays  
Spontaneous reversal frequency was scored on NGM plates with freshly seeded 
OP50. The animals were transferred from their culture plate to a new plate, and 
allowed to recover for 1 min. After the recovery period the number of reversals 
was counted for 3 min. To quantify the instantaneous velocity and average 
forward velocity, animals were transferred from their culture plate to a new NGM 
plate seeded with a thin bacterial lawn and allowed to recover for 1 min. After the 
recovery period the animals were tracked for 90 sec using a single worm tracker 
50. Videos were recorded at 30 frames per second and each frame was 
analyzed with CoLBeRT associated software 51 to measure instantaneous 
velocity of single animals. Reversals, as well as 10 frames before and following 
each reversal, were discarded from the average forward velocity. To examine 
defects in movement, individual young adult worms were transferred into 96-well 
plates containing 50 µl M9 buffer in each well. After a 30 sec recovery period, 
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body bends were counted for 30 sec. A body bend was defined as a change in 
direction of bending at the mid-body. Egg-laying assays were performed as 
described by Koelle and Horvitz (1996). Rates of egg-laying behaviors were 
measured by two different assays: 1) the numbers of unlaid fertilized eggs 
accumulated inside of adult animals, and 2) the developmental stages of freshly 
laid eggs. Briefly, in both assays, L4 larvae were isolated and allowed to develop 
for 40 hr. In the first method, the adults were then incubated in 96-well plates 
containing 1% sodium hypochlorite until the bodies were dissolved. In the second 
method, the adults were transferred to a fresh plate. After 30 min, the 
developmental stage of each freshly laid egg was determined by viewing under a 
high magnification dissecting microscope. 
All pharmacological assays were done in 3 cm petri dishes. For aldicarb 
and levamisole assay, young adult animals were transferred to NGM plates 
supplemented with final concentration1 mM aldicarb and 0.5 mM levamisole 
respectively. The percentage of paralyzed animals was scored at 15 min 
intervals until every assayed animal was paralyzed. Animals were scored as 
paralyzed when they did not move when prodded with a platinum wire. For 
muscimol assays, young animals were placed onto NGM plates containing 1 mM 
muscimol and allowed to equilibrate for 1 hr. The rubberband response was 
scored by gently touching each worm across its body, just posterior to the 
pharynx. Each worm was scored five times. The responses to touch were scored 
according to the presence of a contraction–relaxation cycle and backward 
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movement in the following manner (de la Cruz et al., 2003): 0, worms did not 
contract and relax but moved away from the touch; 1, worms quickly contracted 
and relaxed and moved away from the touch; 2, worms contracted and relaxed 
while concurrently generating a small backward displacement (less than one-half 
of body length); 3, worms contracted and relaxed but failed to move backwards; 
4, worms incompletely contracted and relaxed and produced no displacement.  
 
Electrophysiology  
A stable HEK293 cell line expressing the calcium channel auxiliary subunits β1c 
and α2δ 24 was used to transiently transfect 5 µg of the wild-type or G1518R 
CaV2.1 α1 subunit using the calcium phosphate method. A plasmid encoding the 
green fluorescent protein (pGreen lantern) was also transfected to allow 
identification of transfected cells. Cells were cultured at 37°C in DMEM 
supplemented with 10% fetal bovine serum and 1000 U/ml penicillin–
streptomycin.  
Whole-cell inward currents were recorded 24–36 hr after transfection with 
a HEKA EPC-9 patch clamp amplifier. Recordings were filtered at 2 kHz and 
acquired using Patchmaster software (HEKA). The extracellular recording 
solution contained 5 mM BaCl2, 1 mM MgCl2, 10 mM HEPES, 40 mM TEACl, 10 
mM glucose, and 87.5 mM CsCl, pH 7.4. Typically the pipettes exhibited 
resistances ranging from 2 to 4 MΩ and were filled with internal solution 
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containing: 105 mM CsCl, 25 mM TEACl, 1 mM CaCl2, 11 mM EGTA, and 10 
mM HEPES, pH 7.2.  
Cell capacitance (16.7 ± 6.7 pF; n = 24) and series resistance (9.7 ± 4.6 
MΩ before compensation; n = 24) were measured from the current transient after 
a voltage pulse from -80 to -90 mV. Series resistance was typically compensated 
by 80–90%. Cells with large currents in which errors in voltage control might 
appear were discarded. I-V curves were generated by measuring the peak 
currents obtained after stepping the membrane potential from a holding potential 
of -120 mV to voltages between -55 and 40 mV in 5 mV increments for 200 
msec. I-V curves were fitted with Equation 1.: I= G( G – Erev) (1+exp (V0.5- 
V)/ka)-1 where G is membrane conductance, Erev is the reversal potential, V0.5 
is the midpoint, and ka the slope of the voltage dependence. Current densities 
were obtained by dividing the current peak amplitude to the cell capacitance for 
each experiment.  
To measure steady-state inactivation profiles, conditioning prepulses (10 
sec) from -90 to 20 mV in 10mV steps were applied, and the membrane was then 
stepped to the peak of the I–V curve. Currents were normalized to the maximal 
value obtained at the test pulse and plotted as a function of the prepulse 
potential. Data were fitted with Boltzmann equations: I/Imax= {1 + exp[(V-
V0.5)/kin]-1}  
Data analysis was performed using the IgorPro software (WaveMetrics 
Inc., Lake Oswego, OR); figures, fitting and statistical analysis were done using 
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the SigmaPlot software (version 11.0; Systat Software Inc.). Data are presented 
as mean ± SD. Significant differences were determined using Student’s t test 
with the significance value set at p˃0.01.  
Spontaneous postsynaptic currents were recorded from body wall muscles 
as previously described [Francis et al, 2005 Neuron]. All electrophysiology 
experiments were carried out at room temperature. The extracellular solution 
consisted of 150 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1 mM CaCl2, 15 mM 
HEPES, and 10 mM glucose (pH 7.4, osmolarity adjusted with 20 mM sucrose). 
The intracellular fluid (ICF) consisted of 25 mM K-gluconate, 115 mM KCl, 0.1 
mM CaCl2, 50 mM HEPES, 5 mM Mg-ATP, 0.5 mM Na-GTP, 0.5 mM cGMP, 0.5 
mM cAMP, and 1 mM BAPTA (pH 7.4, osmolarity adjusted with 10 mM sucrose). 
The membrane potential was clamped at -60 mV. Data were digitized at 6.67 kHz 
and low pass filtered at 3.3 kHz. Membrane capacitance and the series 
resistance (at least 20%, up to 60%) were compensated, and only recordings in 
which the series resistance was stable throughout the course of the recording 
were included. Endogenous synaptic activity data were collected in continuous 
mode (saved as 30-s recording sweeps). Data analysis and graphing were 
performed using Excel (Microsoft), Igor Pro (WaveMetrics Inc.), and GraphPrism 
(GraphPad Software). Mini Analysis software (Synaptosoft Inc.) was used to 
detect and analyze the endogenous events off-line.  
 
Microscopy  
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Animals were mounted on 2% agarose pads containing 60 mM sodium azide for 
5 minutes before being examined for fluorescent protein expression and 
localization patterns. Images were captured under consistent detector settings 
with a Hamamatsu Photonics C2400 CCD camera on a Zeiss Axioplan2 Imaging 
System. Images were projected into a single plane using NIH ImageJ software.  
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Figure II-1. zf35 animals are hyperactive in locomotion and the egg-laying 
behavior. (a) Representative traces from single worm tracking showing instant 
velocity of indicated genotypes on OP50 thin lawn plates. Positive and negative 
values indicate forward and backward locomotion, respectively. zf35 mutants 
have increased velocity and reversal numbers compared with wild-type animals. 
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(b) Shown is the average instant forward velocity from single worm analysis for 
the wild type (0.118 ± 0.01 wormlength/sec, n=9), zf35 (0.156 ± 0.01 
wormlength/sec, n=10), zf35 /+ (0.155 ± 0.01 wormlength/sec, n=10) (c) 
Quantification of the reversal frequency in 3 minutes on regular OP50 plates: 
average reversal numbers made by wild type (6.8 ± 0.4 reversals, n=59), zf35 
(43.1± 2.0 reversals, n=59) and zf35/+ (33.2 ± 1.6 reversals, n=23). Error bars 
represent SEM for at least three trials totaling 60 animals. Statistical difference 
from wild type *p<0.05, ****p<0.0001, One way ANOVA with Dunnett’s multiple 
comparisons test (d) Representative Nomraski (DIC) images of unlaid eggs in 
adult wild type and zf35 animals. Arrows indicate eggs; asterisk denotes the 
position of the vulva. The average numbers of eggs in the uterus: wild type (14.1 
± 0.6 eggs, n=80), zf35 (3.6 ± 0.2 egg, n=86). (e) Distribution of stages of freshly 
laid eggs of wild type (1-16 cell stage: 5.2 ± 4.3%, 17-comma stage: 94.3 ± 4.5%, 
post comma stage: 0.8 ± 1.8%) and zf35 mutants (1-16 cell stage: 42.5 ± 16.7%, 
17-comma stage: 57.5 ± 16.7%, post comma stage: 0%). Five independent trials 
totaling 75 animals for each genotype. Statistical difference from wild type 
****p<0.0001, Chi-square.  
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Figure II-2. zf35 is a novel allele of the CaV2α1 subunit gene unc-2. (a) The 
genetic map and gene structure of unc-2. Coding sequences are represented as 
black boxes. The zf35 allele is a single nucleotide transition (GGA -> AGA) 
resulting in a glycine to arginine (G -> R) amino acid substitution at position 1132. 
(b) Diagram of the secondary structure of UNC-2. UNC-2 consists of four TM 
domains (TM I – TM IV) each containing six alpha-helix segments (S1 – S6). The 
UNC-2 (G1132R) mutation localizes in the intracellular loop between 
transmembrane (TM) domain III and IV, indicated by the blue circle. Purple 
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circles indicate positions of intragenic unc-2(zf35) suppressors, red circles 
indicate the location of human FHM1 mutations. (c) The G1132R mutation occurs 
in a highly conserved region of the CaV2 α1 subunit. Amino acid alignment of the 
transmembrane III alpha-helix segment 6 (TM III S6) and third intracellular loop 
of CaV2 α1 subunits from human (H.sapiens, CACNA1A), rainbow fish 
(P.reticulata, cacna1a), fly (D.melanogaster, Cacophony) and nematode (C. 
elegans. UNC-2). Identities are shaded in dark grey, similarities in light grey. 
Location of the G1132R mutation is indicated.  
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Figure II-3. CaV2α1/unc-2(zf35) mutation is a gain-of-function allele of unc-2 
(a) Quantification of the reversal frequency: wild type (6.5 ± 0.4, n=73), unc-
2(zf35gf) (41.0± 2.0, n=69), unc-2(lf) (2.2 ± 0.3, n=63), unc-2(lf) rescued with 
unc-2(wt) transgene (7.5 ± 0.6, n=10) and unc-2(lf) rescued with unc-2(zf35gf) 
transgene (29 ± 2.9, n=26). Statistical difference from wild type ****p<0.0001, 
One way ANOVA with Dunnett’s multiple comparisons test (b) Intragenic unc-2(lf) 
suppressors suppress unc-2(zf35gf) hyperactive locomotion. Shown are numbers 
of thrashes in 30 seconds in M9 for the wild type (107.0± 14.0, n=60), unc-
2(zf35gf) (128.1± 13.5, n=60), unc-2(lf) (4.8± 2.1, n=60), unc-2(zf35gf);unc-
2(zf109) (6.9±4.3, n=60); unc-2(zf35gf);unc-2(zf113) (5.6±3.7 thrashes, n=60); 
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unc- 2(zf35gf);unc-2(zf114) (80.2±9.9, n=60); unc-2(zf35gf);unc-2(zf115) 
(6.9±3.8, n=60); unc-2(zf35gf);unc- 2(zf124) (5.3±3.1, n=60); unc-2(zf35gf);unc-
2(zf130) (67.1±22.5, n=60); unc-2(zf35gf);unc-2(zf134) (31.2±17.9, n=60). Error 
bars represent SEM. Statistical difference from unc-2(zf35gf) mutants 
****p<0.0001, One way ANOVA with Dunnett’s multiple comparisons test. (c) 
Representative images of GFP tagged UNC-2(wt) and UNC-2(zf35gf) in the 
ventral nerve cord. Asterisks point the cell bodies of the motor neurons and 
arrows indicate the presynaptic sites. Both constructs are expressed under pan-
neuroanal promoter tag-168. Scale bar, 10 µm.   
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Figure II-4. Cell-specific expression of the unc-2(zf35gf) transgene is 
sufficient to hyperactivate targeted neurons. (a) List of transgenes and 
expression patterns. Ptag- 168, Plgc-55s(AVB), Prig-3, Pnmr-1, Pacr-2, Punc-47 
and Ptph-1. (b) Schematic representation of neurons in egg-laying circuit and 
locomotion circuit. Synaptic connections as described by White et al. (c) Average 
numbers of eggs in the uterus of adult wild type (14.1 ± 0.6 eggs, n=80), unc-
2(zf35gf) (3.6 ± 0.2, n=86) and Ptph-1::unc-2(gf) (7.9 ± 0.4, n=56). Animals 
carrying transgene which does not affect the egg laying circuit Pacr-2::unc-2(gf) 
are used as control (13.5 ± 0.7, n=20). Error bars represent SEM for at least 
three trials totaling 60 animals. (d) Distribution of stages of freshly laid eggs by 
indicated genotypes. unc-2(zf35gf) mutants and Ptph-1::unc-2(gf) animals lay 
eggs at an earlier stage (1-16 cell stage) compared with wild-type animals. 
****p<0.0001, Chi-square. (e) Average numbers of reversals in 90 seconds of 
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wild type (4.1 ± 0.5, n=37), unc-2(zf35gf) mutants (26.67 ± 2.2, n=9), Ptag- 
168::unc-2(gf) (24.80 ± 2.9, n=10), Plgc-55s:: unc-2(gf) (3.1 ± 0.4, n=30), Prig-3:: 
unc-2(gf) (7.1 ± 0.8, n=16), Pnmr-1:: unc-2(gf) (14.0 ± 1.6, n=11) and Pacr-2:: 
unc-2(gf) (2.2 ± 0.5, n=10), on OP50 thin lawn plate food. Error bars represent 
SEM for at least three trials totaling 60 animals. (f) Quantification of movement 
on 1 mM aldicarb. Each data point represents the mean ± SEM of the percentage 
of animals paralyzed every 15 minutes. Pacr-2::unc-2(gf) animals are more 
sensitive to 1 mM aldicarb compared with wild type, while Punc-47::unc-2(gf) 
animals are resistant to 1 mM aldicarb. Animals carrying transgene which does 
not affect the NMJ acetylcholine release Ptph- 1::unc-2(gf) animals are used as 
control. (g) Maximum amplitude during movements on OP50 thin lawn plates of 
indicated genotypes: wild type (148.6 ± 4.1, n=22), unc-2(zf35gf) mutants (200.5 
± 5.8, n=11), Plgc-55s:: unc-2(gf) (153.1 ± 6.2, n=22), Prig-3:: unc-2(gf) (158.5 ± 
11.6, n=11), Pacr-2:: unc-2(gf) (183.6 ± 6.3, n=13) and Punc-47:: unc-2(gf) (146 
± 3.9, n=12). (h) Head tip motion during movements on OP50 thin lawn plates of 
indicated genotypes: wild type (0.72 ± 0.02, n=23), unc-2(zf35gf) mutants (1.01 ± 
0.03, n=12), Plgc-55s:: unc-2(gf) (0.68 ± 0.02, n=23), Prig-3:: unc-2(gf) (0.64 ± 
0.02, n=12), Pacr-2:: unc-2(gf) (0.79 ± 0.02, n=14) and Punc-47:: unc-2(gf) (0.62 
± 0.02, n=13). Error bars represent SEM. Statistical difference from wild type * 
p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, One way ANOVA with Dunnett’s 
multiple comparisons test.  
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Figure II-5. The UNC-2(ZF35) corresponding G1518R mutation in human 
CaV2α1 subunit results in increased channel activity. (a) Representative 
macro-currents of wild type and G1518R CaV2 channels. Currents were 
generated by stepping membrane potential to voltages between -55 and 40 mV 
in 5mV increments for 200 ms from a holding potential of -120 mV. (b) Voltage 
dependence of whole-cell current density for wild type and G1518R CaV2 
channels. Current density values were obtained by dividing current amplitudes 
and cell capacitance. (Wild type, n=9; G1518R, n=11). (c) Voltage dependence 
of Ba++ current activation. The activation curve of G1518R exhibits a significant 
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shift of the V0.5 value towards more negative membrane potentials. (d) Steady-
State Inactivation curves. The G1518R mutation causes a slight positive shift in 
the midpoint voltage in the steady-state inactivation curves (V0.5inact= -55.0 ± 
1.0 and - 47.3 ± 1.0 for wild type and G1518R, respectively). Currents were 
normalized to the maximal value obtained at the test pulse and plotted as a 
function of the prepulse potential. Data were fitted with the Boltzmann equation: 
(I/Imax={1+exp[(V-V0.5)/kin]} - 1)  
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Figure II-6. FHM1 mutations in unc-2 result in a hyperactive phenotype.   
(a) The amino acid alignment of the conserved region of transmembrane domain 
I membrane-spanning segments 4 (TM I S4) and first intracellular loop from 
human (CACNA1A) and worm (UNC-2) CaV2.1α1 subunits. Identities are dark 
grey and similarities are light grey. Indicated are the known human FHM1 
mutations: R192Q (Hans et al., 1999b) and S218L (Tottene et al., 2005). (b) 
Transgenic animals expressing pan-neuronal unc-2 with either the R192Q or 
S218L mutation have an increased reversal rate compared to wild type. Shown is 
the average number of reversals in 90 seconds of wild type (4.2 ± 0.5, n=29), 
unc-2(zf35gf) (30.3 ± 1.2, n=20), Ptag-168:: unc-2(R192Q) (25.5 ± 0.9, n=34), 
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and Ptag-168:: unc-2(R192Q) (16.5 ± 0.9, n=33). (c) Transgenic animals 
expressing pan-neuronal unc-2 with either the R192Q or S218L mutation display 
hyperactive egg laying behavior. Average numbers of eggs in the uterus of are: 
adult wild type (16.5 ± 0.8 eggs, n=23), unc-2(zf35gf) (2.7 ± 0.2, n=35), Ptag-
168:: unc-2(R192Q) (5.7 ± 0.4, n=37), and Ptag-168:: unc-2(S218L) (8.4 ± 0.6, 
n=32). Each bar represents the mean ± SEM for at least three trials, totaling a 
minimum of 30 animals. Statistical difference from wild-type, ****p<0.0001, one 
way ANOVA with Dunnett’s multiple comparisons test.  
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Figure II-7. GLR-1 mediated signaling contributes to the hyperreversal 
phenotype of unc-2(zf35gf) mutants. Quantification of reversal numbers in 90 
seconds of indicated genotypes. Average reversal numbers made by wild type 
(3.48 ± 0.7 reversals, n=15), unc-2(zf35gf) (31.2 ± 1.4 reversals, n=10), eat-4 
(0.78 ± 0.3 reversals, n=13), glr-1 (0.5 ± 0.2 reversals, n=12), eat-4; unc-
2(zf35gf) (6.18 ± 0.9 reversals,) and glr-1; unc-2(zf35gf) (11.59 ± 0.8 reversals, 
n=27). Error bars represent S.E.M. * represents statistical difference from the 
wild type, **** p<0.0001, one way ANOVA with Dunnett’s multiple comparisons 
test.  
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Figure II-8. unc-2(zf35gf) mutants have increased ACh neurotransmission.  
(a) Quantification of movement on 1 mM aldicarb. Each data point represents the 
mean ± SEM of the percentage of animals paralyzed every 15 minutes. 50% of 
the wild type animals were paralyzed at 60 minutes. unc-2(lf) animals were 
resistant to the effects of aldicarb and reached 50% paralysis at 90 minute. 
Homozygous unc-2(zf35gf) mutants were sensitive to aldicarb; 50% of the unc-
2(zf35gf) mutants were paralyzed at 20 minute. Heterozygous unc-2(zf35gf) 
mutants have 50% paralysis at 40 minutes, which further confirmed that the unc-
2(zf35gf) allele is semi-dominant. (b) Quantification of paralysis percentage on 1 
mM aldicarb at the 60-minute time point: 55.5% ± 4.5 of wild type, 56.7% ± 3.3 of 
Ptag-168::unc-2(wt), 98.3% ± 3.3 of Ptag-168::unc-2(zf35gf), 27.1% ± 7.3 of unc-
2(lf) animals, 54.8% ± 2.9 of Ptag-168::unc-2(wt) transgene in unc-2(lf) 
background, 100% of Ptag-168::unc-2(zf35gf) transgene in unc-2(lf) background, 
100% of Ptag-168::unc-2(R192Q) transgene in unc-2(lf) background and 100% 
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Ptag-168::unc-2(S218L) transgene in unc-2(lf) background. Three independent 
trials with totaling 50 animals for each genotype. ****p<0.0001, one way ANOVA 
with Dunnett’s multiple comparisons test.  
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Figure II-9. unc-2(zf35gf) mutants have increased cholinergic and 
decreased GABAergic transmission. (a) Representative traces of total 
endogenous postsynaptic currents recorded (mPSCs) from ventral body wall 
muscles in wild-type and unc-2(zf35gf) mutants. (b and c) Average endogenous 
mPSCs frequency and amplitude of wild-type and unc-2(zf35gf) mutants. (d) 
Representative traces of endogenous cholinergic mEPSCs in wild-type and unc-
2(zf35gf) mutants. (e and f) Average mEPSCs frequency and amplitude of wild-
type and unc-2(zf35gf) mutants. (g) Representative traces of endogenous 
GABAergic mIPSCs in wild-type and unc-2(zf35gf) mutants.  (h and i) Average 
mIPSCs frequency and amplitude of wild-type and unc-2(zf35gf) mutants. Error 
bars depict SEM. *p<0.05, **p<0.01, two-tailed Student’s t test.  
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Figure II-10. unc-2(zf35gf) mutants have decreased GABA receptor 
expression at the NMJ. (a) Schematic of the neuromuscular junction (NMJ) of 
the ventral nerve cord (VNC) motorneurons. C. elegans forms en passant 
synapses, with presynaptic regions along the length of the ventral nerve cord, 
indicated as red. Postsynaptic receptors expressed in muscle cells represented 
as green. (b) Representative images of cholinergic synapses in wild type and 
unc-2(zf35gf) mutants. Presynaptic sites are labeled with synaptic vesicle marker 
RAB-3::mCherry while postsynaptic nicotinic acetylcholine receptors are labeled 
by UNC-29::GFP. Scale bar represents 10 µm. (c and d) Quantification of the 
fluorescence intensity of RAB-3::mcherry and UNC-29::GFP along the nerve cord 
at cholinergic synapses in wild type and unc-2(zf35gf) mutants. Arbitrary 
fluorescence units of individual animals are normalized to the mean value of wild 
type. Normalized fluorescence of cholinergic RAB-3::mCherry: 0.99 ± 0.76, n=21 
in wild type and 1.36 ± 0.18, n=14 in unc-2(zf35gf) mutants. UNC-29::GFP: 0.97 
± 0.05, n=35 in wild type and 1.19 ± 0.06, n=38 in unc-2(zf35gf) mutants. (e) 
Representative images of GABAergic synapses in wild type and unc-2(zf35gf) 
mutants. Presynaptic sites are labeled with synaptic vesicle marker RAB-
3::mCherry while postsynaptic GABA receptors are labeled by UNC-49::GFP. 
Scale bar represents 10 µm. (f and g) Quantification of the fluorescence intensity 
of RAB-3::mcherry and UNC-49::GFP along the nerve cord at GABAergic 
synapses in wild type and unc-2(zf35gf) mutants. Arbitrary fluorescence units of 
individual animals are normalized to the mean value of wild type. Normalized 
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fluorescence of GABAergic RAB-3::mCherry: 1 ± 0.07, n=15 in wild type and 1.25 
± 0.08, n=20 in unc-2(zf35gf) mutants. UNC-49::GFP: 1 ± 0.09, n=15 in wild type 
and 0.75 ± 0.06, n=20 in unc-2(zf35gf) mutants. For all the quantification above, 
error bars depict SEM. *p<0.05, **p<0.01, two-tailed Student’s t test. 
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Figure II-11. unc-2(zf35gf) mutants are resistant to the GABA agonist 
mucimol. (a) Quantification of movement on 0.5 mM levamisole. Each data point 
represents the mean ± SEM of the percentage of animals paralyzed by 
levamisole every 15 minutes for at least three trials, totaling a minimum of 50 
animals. (b) unc-2(zf35gf) mutants are resistant to the muscimol-induced muscle 
relaxation compared with the wild type in rubberband phenotype.. Shown is the 
percentage of animals that displayed the indicated phenotype on 1 mM muscimol 
after 60 min. Wild type animals: category 0: 0%, category 1: 3 ± 2.9%, category 
2: 17 ± 5.8%, category 3: 62 ± 2.7% and category 4: 32 ± 13.7%. unc-2(zf35gf) 
mutants: category 0: 12 ± 3.3%, category 1: 33 ± 2.2%, category 2: 26 ± 2.4%, 
category 3: 25 ± 4.5% and category 4 and 3 ± 1%. Severity of muscimol-induced 
phenotype is increased from 0 (normal locomotion) to 4 (complete flaccid 
paralysis) (see Materials and Methods for scoring details). * p<0.05, ***p<0.001 
between wild type and unc-2(zf35gf) mutants, Chi-square.   
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Figure II-11. unc-2(zf35gf) mutants are resistant to the GABA agonist 
mucimol. (a) Quantification of movement on 0.5 mM levamisole. Each data point 
represents the mean ± SEM of the percentage of animals paralyzed by 
levamisole every 15 minutes for at least three trials, totaling a minimum of 50 
animals. ***p<0.001 between wild type and unc-2(zf35gf) mutants, two-way 
ANOVA. (b) unc-2(zf35gf) mutants are resistant to the muscimol-induced muscle 
relaxation compared with the wild type in rubberband phenotype.. Shown is the 
percentage of animals that displayed the indicated phenotype on 1 mM muscimol 
after 60 min. Wild type animals: category 0: 0%, category 1: 3 ± 2.9%, category 
2: 17 ± 5.8%, category 3: 62 ± 2.7% and category 4: 32 ± 13.7%. unc-2(zf35gf) 
mutants: category 0: 12 ± 3.3%, category 1: 33 ± 2.2%, category 2: 26 ± 2.4%, 
category 3: 25 ± 4.5% and category 4 and 3 ± 1%. Severity of muscimol-induced 
phenotype is increased from 0 (normal locomotion) to 4 (complete flaccid 
paralysis) (see Materials and Methods for scoring details). ****p<0.0001 between 
wild type and unc-2(zf35gf) mutants, two-way ANOVA.   
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Figure II-12. The reduction of GABA receptor in unc-2(zf35gf) mutants is 
dependent on nicotinic acetylcholine receptor mediated signaling. (a) 
Representative images of GABAergic presynaptic sites labeled with RAB-
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3::mcherry of indicated genotypes. Scale bar represents 10 µm (b) Quantification 
of the fluorescence intensity of RAB-3::mcherry along the nerve cord of indicated 
genotypes. Arbitrary fluorescence units of individual animals are normalized to 
the mean value of wild type. Normalized RAB-3::mCherry fluorescence: wild type 
(1 ± 0.05, n=42), unc-2(zf35gf) (1.5 ± 0.09, n=15), PGABA::unc-2(zf35gf) (1.3 ± 
0.08, n=14), acr-12; unc-2(zf35gf) (1.2 ± 0.06, n=15) and unc-29; unc-2(zf35gf) 
(1.21 ± 0.08, n=14). (c) Representative images of GABA receptor UNC-49::GFP 
of indicated genotypes. Scale bar represents 10 µm. (d) Quantification of the 
fluorescence intensity of UNC-49::GFP along the nerve cord of indicated 
genotypes. Arbitrary fluorescence units of individual animals are normalized to 
the mean value of wild type. Normalized UNC-49::GFP fluorescence: wild type (1 
± 0.06, n=41), unc-2(zf35gf) (0.4 ± 0.07, n=15), PGABA::unc-2(zf35gf) (1.5 ± 0.12, 
n=13), acr-12; unc-2(zf35gf) (1 ± 0.11, n=15) and unc-29; unc-2(zf35gf) (0.9 ± 
0.07, n=14).  For all the quantification above, error bars depict SEM. *p<0.05, 
*p<0.01, ***p<0.001, ****p<0.0001, one way ANOVA with Dunnett’s multiple 
comparisons test.   
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Figure II-13. Proposed model of the imbalance between excitatory and 
inhibitory neurotransmission in unc-2(zf35gf) mutants     
Wild-type animals: ! CaV2α1/unc-2(zf35gf) mutants: !
An imbalanced excitatory-inhibitory neurotransmission 
in the gain-of-function calcium channelopathy  
sustained!depolariza/on!
CAV1!(EGL819)!
Ca2+!
Wild-type animals: ! CaV2α1/unc-2(zf35gf) mutants: !
An imbalanced excitatory-inhibitory neurotransmission 
in the gain-of-function calcium channelopathy  
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CHAPTER III 
 
 
 
 
A Forward Genetic Screen for Regulators of Calcium Channel Function  
in Synaptic Transmission 
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Introduction 
Presynaptic CaV2 channels play a central role in the function of the nervous 
system including calcium-dependent gene expression, neuronal migration, and 
neurotransmitter release (Catterall 2000; West et al. 2001). Inherited gene 
mutations disrupting presynaptic CaV2 function can result in human epilepsy, 
migraine, autism-spectrum disorders and bipolar disease, underscoring the 
importance of these channels in human physiology (Bidaud et al., 2006; 
Pietrobon, 2010).  
 Presynaptic CaV2 channels are particularly crucial for synaptic 
transmission, which is a major mechanism of communication between neurons. 
Biochemical and molecular studies have identified and elucidated some proteins 
and their roles in modulating CaV2 channel function (Catterall 2011; Simms and 
Zamponi 2014). Genetic approaches using C. elegans can further complement 
these studies not only by assessing the functional importance of individual 
proteins in living animals, but also by identifying additional modulatory 
components (Miller et al., 1996). The isolation of the CaV2α1/unc-2(zf35gf) 
mutants opened a unique and powerful opportunity to elucidate regulatory 
mechanisms underlying Cav2 channel function, modulation and localization in 
vivo. Therefore, we carried out an unbiased forward genetic suppressor screen, 
and identified new alleles of genes that genetically interact and modulate CaV2 
channel function in synaptic transmission.  
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 Through this suppressor screen of CaV2α1/unc-2(zf35gf) mutants, we 
isolated alleles of genes that have been shown to play a role in in synaptic 
vesicle release, Cav2 channel trafficking and localization as well as components 
of the channel complex, suggesting our screening approach was successful. 
CaV2 channels are heteromultimeric membrane complexes that are composed of 
a pore-forming CaVα1 subunit together with two indispensible auxiliary subunits, 
CaVα2δ and CaVβ. Loss of CaVβ subunit function is detrimental and can lead to 
lethality from worms to mice (Ball et al., 2002; Burgess et al., 1999; Lainé et al., 
2011; Strube et al., 1996). ccb-1 encodes the CaVβ subunit in C. elegans and 
ccb-1 null mutants are embryonic lethal (Lainé et al., 2011). We isolated a 
previously unavailable viable hypomorphic allele of ccb-1, and showed that CaVβ 
/CCB-1 functions in neurons and muscles to generate coordinated behaviors. In 
addition to genes previously implicated in Cav2 channel function, we recovered 
alleles of genes that are less characterized with their roles in modulating Cav2 
channels. Uncovering their roles will potentially illuminate new mechanisms for 
regulating calcium dependent synaptic transmission.  
 
Results 
Isolation and identification of presynaptic CaV2 channel regulators 
The C. elegans genome encodes a single presynaptic CaV2α1 subunit, 
UNC-2. We have previously reported CaV2α1/unc-2(zf35gf) mutants have 
increased acetylcholine (ACh) transmission and are hypersensitive to the 
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cholinesterase inhibitor, aldicarb. Aldicarb causes hypercontracted paralysis as 
well as the cessation of growth and reproduction (Miller et al., 1996). To identify 
genes that are required for expression, trafficking, and composition of CaV2 
channels, we performed a forward genetic screen looking for mutants that 
suppres the aldicarb hypersensitivity in the unc-2(zf35gf) mutant background. To 
focus on mutations that affect presynaptic function, a secondary screen with the 
cholinergic agonist, levamisole, was performed. Since levamisole directly 
activates postsynaptic receptors, mutants that are resistant to this drug in 
addition to aldicarb have a postsynaptic defect rather than a defect at the 
presynapse. We isolated 29 alleles from the screen in total and identified causal 
mutations for 28 alleles using genetic analysis and single nucleotide 
polymorphisms (SNPs) mapping combined with whole genome sequencing.  
Table III-1 lists the genes that were identified in the screen and the 
number of alleles for each gene. Two gene classes account for the majority of 
the suppressors: CaV2 complex components and presynaptic active zone 
proteins. We obtained seven intragenic alleles of the CaV2α1 subunit unc-2 as 
well as alleles of other auxiliary subunit, CaVα2γ/ccb-1 and CaVβ/unc-36. 
Interestingly, we isolated one allele of the CaV1α1 subunit egl-19, suggesting a 
presynaptic interaction between these two types of CaV channels. Core active 
zone proteins are crucial for CaV2 channel function in synaptic transmission. We 
isolated alleles of unc-10/Rim which are essential for synaptic vesicle docking 
and priming, as well as for recruiting CaV2 channels to active zones (Gracheva 
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et al., 2008; Han et al., 2011; Kaeser et al., 2011) and alleles of unc-13/Munc13 
and unc-18/Munc18 (Südhof, 2012). In addition to components of the CaV2 
complex and active zone proteins, we isolated one allele of calf-1, a nematode-
specific single transmembrane ER protein required to traffic UNC-2 from the ER 
to the surface of the membrane (Saheki and Bargmann, 2009). We also isolated 
mutations in two genes with no implicated roles in synaptic transmission so far: 
unc-31/CAPS and mec-9. unc-31/CAPS is required for dense core vesicle fusion 
and mec-9 is a predicted extracellular matrix protein (Du et al., 1996; Speese et 
al., 2007). Genes from the suppressor screen are summarized in Figure III-1. 
These results show that our screening approach was highly successful in 
identifying genes that regulate the CaV2 channel function as well as opening new 
avenues for understanding the CaV2 channel mediated neurotransmission.  
 
A mutation in the CaVβ subunit ccb-1 suppresses the aldicarb 
hypersensitivity of CaV2α1/unc-2(zf35gf) mutants 
 Despite the biophysical and pharmacological properties of CaV channels 
are largely determined by the CaVα1 subunit, proper surface expression and 
function of these channels require the auxiliary subunits. From the suppressor 
screen, we isolated an allele, zf121, of the CaVβ subunit ccb-1 gene, which 
partially suppresses the aldicarb hypersensitivity of CaV2α1/unc-2(zf35gf) 
mutants (Figure III-2a). CaVβ subunits have a common structure consisting of the 
N and C termini, which are relatively variable and subject to alternative splicing, 
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and a highly conserved core region comprised of an Src homology 3 (SH3) 
domain and an enzymatic inactive guanylate kinase (GK)-like domain which are 
connected by the HOOK domain (Chen et al. 2004). Sequence analysis revealed 
the zf121 allele contains a single amino acid substitution (isoleucine to threonine) 
in the highly conserved SH3 domain (Figure III-2b).  
Two putative CaVβ subunits, ccb-1 and ccb-2, are present in the C. 
elegans genome based on sequence similarity with mammalian β subunits. 
Research has shown that CCB-1 is indispensible for voltage-dependent calcium 
currents in C. elegans muscle cells (Lainé et al., 2011). The identification of the 
ccb-1(zf121) allele from our CaV2α1/unc-2(zf35gf) suppressor screen shows that 
CCB-1 function is also crucial in neurons.   
 
CCB-1 localizes to the presynaptic release sites  
Expression of a biologically active, GFP-tagged CCB-1 protein driven by 
its native promoter is detected in most neurons as well as pharyngeal and body 
wall muscles (Figure III-2c). To achieve better spatial resolution of the subcellular 
localization of CCB-1, we expressed the GFP::CCB-1 only in GABAergic motor 
neurons. We were able to observe the GFP::CCB-1 signal colocalized with the 
mCherry-labeled synaptic vesicle marker RAB-3 along the axon (Figure III-2d), 
indicating CCB-1 localizes to the presynaptic release sites where CaV2 channels 
resided. One intriguing observation was that in addition to being localized to both 
the axon and the cytoplasm, CCB-1 was also found in nuclei of motor neurons 
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(Figure III-2e). As the CaVβ subunit is the only non-membrane anchored subunit 
in the CaV2 channel complex, this CCB-1 nuclear localization may suggest a 
novel role of CaVβ subunits independent of their role in synaptic transmission.       
 
ccb-1(zf121) mutants are sluggish and defective in egg-laying  
The C. elegans genome encodes three CaVα1 subunits: egl-19 (CaV1α1), 
unc-2 (CaV2α1) and cca-1 (CaV3α1) (Jeziorski et al., 2000). Among them, egl-19 
(CaV1α1) and unc-2 (CaV2α1) are high-voltage activated CaV channels and 
require auxiliary subunits, CaVβ and CaVα2γ subunits for proper function (Perez-
Reyes, 2006; Perez-Reyes et al., 1998; Takahashi et al., 1987). CaV1α1/EGL-19 
is expressed in muscle cells and some neurons, and egl-19(lf) mutants are slow, 
defective in egg-laying, and accumulate fertilized eggs in the uterus (Figure III-3a 
and b). CaV2α1/UNC-2 is exclusively expressed in neurons, and unc-2(lf) 
mutants are sluggish and uncoordinated (Figure. III-3a). ccb-1(zf121) mutants, 
similar to egl-19(lf) and unc-2(lf), exhibit decreased locomotor velocity and an 
increased number of eggs in the uterus (Figure III-3a and b), suggesting it plays 
an important role in both EGL-19 and UNC-2 function. The locomotor and egg-
laying phenotypes of ccb-1(zf121) mutants were rescued by wild-type ccb-1 
transgene driven by its native promoter. Expression of ccb-1 specifically in the 
body wall muscles were able to rescue the egg-laying defect, but not the 
sluggishness of ccb-1(zf121) mutants, while expression of ccb-1 specifically in 
the nervous system partially rescued the locomotion but not the egg-laying 
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defects of ccb-1(zf121) mutants. Our results strongly suggest that CCB-1 is the 
main, if not the only, CaVβ subunit required for both EGL-19 and UNC-2 function. 
The results of tissue-specific rescue of ccb-1 support the notion that 
CaV1α1/EGL-19 functions in vulva muscles to regulate egg-laying behavior 
(Raymond et al., 1997; Trent et al., 1983). On the other hand, coordination 
between neurons and muscles is required for proper locomotion behavior 
(Gjorgjieva et al., 2014) and we found that expression of CCB-1 only in neurons 
or muscles is not sufficient to rescue the locomotor defect, strongly suggesting 
that CCB-1 is the main, if not the only, CaVβ subunit required for both EGL-19 
and UNC-2 function.    
 
ccb-1(zf121) mutants are hypersensitive to the cholinergic agonist, 
levamisole 
ccb-1(zf121) mutants are behaviorally defective in locomotion and egg-
laying, suggesting a reduced function of both CaV1/EGL-19 and CaV2/UNC-2 
channels, which function mainly in muscles and presynaptic neurons, 
respectively. To test whether these observed locomotor and egg-laying 
phenotypes of ccb-1(zf121) mutants are the result of impacted synaptic 
transmission, we used pharmacological assays to examine the functional 
consequences of the reduction of function of CaVβ subunits using ccb-1(zf121) 
mutant animals. We placed ccb-1(zf121) mutants on plates containing 1 mM 
aldicarb and analyzed their rate of paralysis compared to wild type. Although we 
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expected the ccb-1(zf121) mutants to be resistant to aldicarb, we unexpectedly 
observed that ccb-1(zf121) mutants showed a wild-type response, suggesting 
normal presynaptic release of acetylcholine (Figure III-4a). We next tested the 
responses of ccb-1(zf121) mutants to the cholinergic agonist, levamisole, and 
found that ccb-1(zf121) mutants were hypersensitive, which suggests an up-
regulation of acetylcholine receptor function (Figure III-4b). The hypersensitivity 
to levamisole of ccb-1(zf121) mutants can be rescued by expression of the wild-
type ccb-1 transgene driven by its native promoter. Because of the increase in 
acetylcholine receptor function, we cannot rule out the possibly that the 
decreased presynaptic release was masked by the increased postsynaptic 
signaling in the aldicarb assay.  
 
The GK domain of CaVβ/CCB-1 is essential for its function  
CaVβ subunits share a common structure with a highly conserved core 
region containing an Src homology 3 (SH3) domain and an enzymatically inactive 
guanylate kinase (GK)-like domain, which are connected by a less conserved 
HOOK region (Chen et al. 2004). While GK domain has been well demonstrated 
with its importance in the direct interaction with the CaVα1 subunit, and regulating 
CaVα1 subunit gating properties and surface expression (Opatowsky et al., 
2004), the roles of SH3 and HOOK domains are less clear . Unlike mammals 
which have four genes that encode CaVβ subunits, ccb-1 is likely the only CaVβ 
gene in C. elegans. This provides an opportunity to investigate the functional 
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significance of different domains in living animals without the complications of 
redundancy. To test which domains of CCB-1 are required for its function, we 
expressed GFP-tagged forms of CCB-1 lacking specific domains under its native 
promoter in the ccb-1(zf121) mutant background (Figure III-5a). We detected 
normal expression and localization of these mutant forms of CCB-1 to neurons 
and muscles (Figure III-5b). At subcellular level, we noticed that the fluorescence 
signal of CCB-1(ΔSH3) and CCB-1(ΔHOOK) was nuclear excluded and 
appeared clumpier compared with the wild type. We also observed that CCB-
1(ΔGK) have fewer puncta along the VNC.  
Functionally, CCB-1(ΔSH3) fully rescued the uncoordinated locomotion of 
ccb-1(zf121) mutants and partially rescued the egg-laying defect. CCB-
1(ΔHOOK) partially rescued both locomotion or egg-laying behaviors and CCB-
1(ΔGK) failed to rescue either of these phenotypes (Figure III-5c and d). These 
results suggest the GK domain of CaVβ/CCB-1 is essential for its function. To 
exclude the possibility that the rescue we observed in ccb-1(zf121) mutants was 
due to an interaction between our deletion constructs with the mutant CCB-
1(I84T) produced in the ccb-1(zf121) mutant background, we performed a rescue 
assay of lethality using a null allele of ccb-1. ccb-1(gk18) allele contains a large 
deletion of the ccb-1 gene and thus is thought to be a null allele. ccb-1(gk18) 
mutants are embryonic arrested and have to be maintained in the balancer strain 
by the translocation szT1 (Lainé et al., 2011). We injected the GFP-tagged 
domain-deleted CCB-1 constructs into ccb-1(gk18) adult animals (P0) and picked 
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the progeny (F1) carrying the transgenes singly to individual plates by selecting 
GFP. We then examined if any of the plates have progenies (F2) that were able 
to reach the adulthood and have lose the balancer. We found that transgenic 
animals carrying CCB-1(ΔSH3) or CCB-1(ΔHOOK) transgenes were able to 
reach the adulthood and produce progeny in the non-balancer background, while 
animals carrying CCB-1(ΔGK) transgene remained embryonic lethal after losing 
the balancer. Taken together, our data show that the GK domain is indispensible 
for the function of CaVβ /CCB-1, and the SH3 and HOOK domain play more 
modulatory roles.   
 
Discussion 
Presynaptic CaV2 channel function is crucial for cell excitability and synaptic 
vesicle release. From a forward genetic screen, we isolated new alleles of genes 
that genetically interact with the CaV2 channel and regulate its function in 
neurotransmission. These genes encode proteins in active zone and synaptic 
vesicle release machinery (unc-10, unc-13 and unc-18), calcium channel 
trafficking and surface expression (calf-1, unc-10, unc-36 and ccb-1), and 
calcium channel auxiliary subunits (unc-36 and ccb-1). This screen was highly 
successful in that many of the genes we recovered have been implicated in 
regulating CaV2 channel function (Gracheva et al., 2008; Kaeser et al., 2011; 
Saheki and Bargmann, 2009).  
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Three suppressors isolated from our screen have not been previously 
implicated in Cav2 channel mediated synaptic transmission, and therefore are 
novel regulators of CaV2 channel function. These include egl-19(zf89), unc-
31(zf107) and mec-9(zf132). egl-19 encodes for the only CaV1α1 subunit in C. 
elegans and is the sole CaV channels in body wall muscles (Lainé et al., 2011). 
EGL-19 is required for muscle contraction during late embryogenesis, 
locomotion, egg-laying, mating and feeding (Garcia et al., 2001). CaV1α1/EGL-19 
is expressed in all muscles as well as some neurons (Raymond et al., 1997), but 
its role in synaptic transmission is less clear compared with presynaptic 
CaV2α1/UNC-2 (Mathews et al., 2003). egl-19(zf89) mutation is sufficient to 
suppress the aldicarb hypersensitivity of CaV2α1/unc-2(zf35gf) mutants without 
altering the postsynaptic levamisole response, indicating this mutation mainly 
affects the EGL-19 function in neurons. Our egl-19(zf89) allele has an amber 
mutation in exon 16 which only affects the egl-19 b isoform, suggesting that egl-
19 b isoform may potentially be the neuronal-specific isoform. C. elegans body 
wall muscles fire all-or-none, calcium-dependent action potentials, and the 
frequency can be regulated by EGL-19 activity in motor neurons (Gao and Zhen, 
2011). The identification of egl-19(zf89) allele from the suppressor screen 
provides a line of evidence that different CaV channel types functionally interact 
in neurons.  
unc-31 encodes the C. elegans ortholog of human calcium-dependent 
activator protein for secretion/CAPS, which has been shown to be required for 
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the dense core vesicle exocytosis (Speese et al., 2007).  unc-31(zf107) has a 
single nucleotide transition that disrupts the 5’ splice donor of exon 9 and affects 
alternative splicing of certain isoforms. Notably, we tested the canonical null 
allele unc-31(e928), which has a large deletion in the unc-31 gene, and found 
this allele failed to suppress the elevated cholinergic neurotransmission in 
CaV2α1/unc-2(zf35gf) mutants. This allele–specific effect is likely due to the 
molecular differences between these two alleles. Strains with the unc-31(e928) 
allele lacked UNC-31 protein (Speese et al., 2007), whereas our unc-31(zf107) 
mutation may lead to alternative splicing of the unc-31 transcript. Munc-13/UNC-
13 is required for synaptic vesicle fusion (Betz et al., 1998). CAPS/UNC-31 and 
Munc13/UNC-13 proteins have related C- terminal SNARE protein–binding 
domains, and both need to translocate to membrane PIP2-rich domains to 
mediate vesicle fusion (Kabachinski et al., 2014). It is possible that our unc-
31(zf107) allele produces mutated UNC-31 that competes with UNC-13 to 
interact with membrane PIP2  and thus suppresses the elevated acetylcholine 
release in CaV2α1/unc-2(zf35gf) mutants. The other gene we isolated is mec-9, 
which encodes the predicted extracellular matrix protein containing EGF repeats, 
Kunitz domains and a glutamate-rich region (Du et al., 1996). While the long 
isoform of MEC-9 is crucial for mechanosensation in C. elegans through its role 
in organizing the mechanosensory channel complex, little is known about the 
function of the short isoform of MEC-9 (Du et al., 1996; Emtage et al., 2004). 
While MEC-9(L) has a narrow expression pattern and is detected only in the six 
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touch neurons, MEC-9(S) is widely distributed in the nervous system including 
neurons in the head and ventral nerve cord (Du et al., 1996), suggesting that the 
MEC-9(S) may play a universal role in all neurons, such as organizing active 
zones. Our allele mec-9(zf132) has an amber mutation in exon 18 which affects 
both isoforms. This may provide a new perspective on mechanistic basis of 
regulation of CaV2 channel function.  
CaVβ auxiliary subunits are crucial for CaV channel function and 
regulation. However, due to complex expression patterns of each subtype and 
specific pairing of different CaVα1 subunit in mammals, most studies of the CaVβ 
subunit have been performed in vitro or in heterologous expression systems. In 
this study, we provided the genetic evidence that CaVβ/CCB-1 regulates 
CaV2/UNC-2 channel function through isolating a hypomorphic ccb-1 allele from 
the CaV2α1/unc-2(zf35gf) suppressor screen (Figure III-1a and b). In addition to 
uncoordinated locomotion, ccb-1(zf121) mutants are defective in egg-laying 
behavior, which is a classical phenotype exhibited by the CaV1/EGL-19 channel 
loss-of-function egl-19 mutants (Raymond et al., 1997) (Figure III-2), suggesting 
CCB-1 function is required by both CaV channel types in C. elegans. ccb-1(zf121) 
mutants are hypersensitive to levamisole (Figure III-3b). This suggests the 
occurrence of a compensatory mechanism in response to the decreased 
presynaptic neurotransmission and decreased calcium currents in body wall 
muscles seen in ccb-1(zf121) mutants. Further investigation into whether this 
increased postsynaptic response result from increased expression or binding 
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efficacy of receptors, or from the signaling factors downstream of ligand binding 
is likely to shed light on homeostatic mechanisms that affect synapse formation 
during development.    
 The ccb-1(zf121) allele has an isoleucine to threonine amino acid 
substitution in the SH3 domain of CaVβ/CCB-1 (Figure III-2b). We tested the 
functional significance of each domain of CCB-1 in vivo by rescuing the ccb-1 
mutants with forms of ccb-1 cDNA with individual domains deleted (Figure III-4a). 
The ccb-1(ΔGK) cDNA construct failed to rescue the lethality of ccb-1 null 
mutants, or behavioral defects of ccb-1(zf121) mutants (Figure III-4c and d). 
Previous work has shown the GK domain of the CaVβ subunit is necessary and 
sufficient for CaV channel surface expression through direct interaction with 
CaVα1 subunits (He et al. 2007). Therefore, we speculate that CaVα1 subunits 
were retained in the ER in the ccb-1 mutants expressing the ccb-1(ΔGK) 
rescuing construct. ccb-1(ΔSH3) and ccb-1(ΔHOOK) cDNA constructs rescued 
the lethality of ccb-1 null allele and only partially rescued the behavioral defects 
of ccb-1(zf121) mutants, suggesting the SH3 and HOOK domains play roles in 
modulation and regulation of CaV channel kinetics. While the HOOK domain has 
been shown to be critical for regulating CaV channel inactivation (He et al. 2007; 
Richards et al. 2007), the functional significance of the SH3 domain remains 
elusive. Studies have shown that the SH3 domain has GK domain-dependent 
low binding affinity with the CaVα1 subunits in vitro (Dubuis et al., 2006), and can 
interact with GK domains intramolecularly (Opatowsky et al. 2004; Chen et al. 
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2004; Van Petegem et al. 2004). Mutations that weaken this intracellular 
interaction severely compromises the gating effects of the CaVβ subunits (Chen 
et al. 2009). Since our ccb-1(zf121) mutation affects a residue within the SH3 
domain, perhaps its ability to suppress the CaV2α1/unc-2(zf35gf) mutants could 
be a result of changes to the 3D folding structure of CaVβ subunits, thus 
impacting critical intramolecular interactions. 
 Taken together, our screen for suppressors of the CaV2α1/unc-2(zf35gf) 
mutants isolated a collection of suppressors including CaV2α1 interacting 
molecules that not found in previous aldicarb-resistance screens (Miller et al., 
1996).  Further genetic and molecular analysis of these new alleles and genes 
will continue to yield insight into the regulation and functioning of the presynaptic 
CaV2 channels, particularly in synaptic transmission. Additionally, through 
isolating a previously unavailable viable hypomorphic allele of CaVβ/ccb-1, we 
show for the first time in C. elegans that the CCB-1 is crucial for presynaptic 
CaV2 channel function, as well as the functional significance of the GK domain of 
CaVβ/CCB-1 in vivo. Overall this work has contributed to the elucidation of 
regulatory mechanisms underlying Cav2 function, modulation, and localization 
using an in vivo system, and has provided many avenues for future 
investigations.  
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Materials and Methods 
Strains  
All strains were cultured at room temperature (22-24 ̊C) on nematode growth 
media (NGM) agar plates with the E. coli strain OP50 as a food source 
Experiments were performed on young adult animals at room temperature (22-
24 ̊C). The wild-type strain was Bristol N2. Transgenic strains were obtained by 
microinjection of plasmid DNA into the germline with coinjection marker lin-15 
rescuing plasmid indicated. At least three independent transgenic lines were 
obtained. The data presented is from a single representative line. The following 
strains were utilized in this study: 
QW37 unc-2(zf35gf)  
QW1092 ccb-1(zf121) 
QW1131 lin-15(n765ts); ccb-1(zf121); zfex469[pccb-1::CCB-1] 
QW1137 lin-15(n765ts); ccb-1(zf121); zfex473[prgef-1::CCB-1] 
QW1140 lin-15(n765ts); ccb-1(zf121); zfex476[pmyo-3::CCB-1] 
QW1181 lin-15(n765ts); zfex489 [pccb-1::gfp::CCB-1]  
QW1305 lin-15(n765ts); ccb-1(zf121); zfex567[pccb-1::CCB-1(deltaGK)] 
QW1309 lin-15(n765ts); ccb-1(zf121); zfex570[pccb-1::CCB-1(deltaHOOK)] 
QW1311 lin-15(n765ts); ccb-1(zf121); zfex572[pccb-1::CCB-1(deltaSH3)] 
QW1400 zfis136 [pccb-1::CCB-1::GFP] 
QW1407 zfIs136[pccb-1::CCB-1::GFP];otIs355 [rab-3::NLS::tagRFP]  
QW1491 ufIs58[Punc-47::mcherry::RAB-3]; zfex687[Punc-47::GFP::CCB-1] 
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EG5819 ccb-1(gk18); oxEx1443[pccb-1::CCB-1 cDNA, pccb-1::GFP::H2B] 
 
Isolation and identification of CaV2α1/unc-2(zf35gf) suppressors  
CaV2α1/unc-2(zf35gf) L4 animals (P0) were mutagenized with 0.5 mM N-ethyl-N-
nitrosourea (ENU) for 4 hr. Approximately 10, 000 F1 animals were bleached to 
obtain F2 eggs. F2 eggs were plated on NGM plates containing 0.25 mM aldicarb 
and examined for viable progeny after 7 and 14 days. Aldicarb resistant animals 
were individually transferred to fresh NGM plates, and their progeny were 
retested for aldicarb resistance and levamisole sensitivity. Suppressors that were 
aldicarb resistant and had either wild type or sensitive responses to levamisole 
were kept further characterization. All suppressors isolated from the screen were 
first backcrossed with wild-type N2. Suppressors that showed linkage to the X 
chromosome were tested for complementation with unc-2(lf) mutants. Molecular 
identities of unc-2 intragenic suppressors were identified by DNA sequencing of 
the unc-2 gene. Other suppressors were first mapped using single nucleotide 
polymorphisms (SNPs) (Wicks et al., 2001) to narrow down the chromosomal 
region and combined with whole genome sequencing to identify possible gene 
candidates and causal mutations. The causative mutations were confirmed by 
complementation test.  
 
Behavioral and pharmacological assays  
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To quantify the instantaneous velocity and average forward velocity, animals 
were transferred from their culture plate to a new NGM plate seeded with a thin 
bacterial lawn and allowed to recover for 5 min. After the recovery period the 
animals were tracked for 90 sec using a multiple worm tracker (MWT) (Swierczek 
et al., 2011). Videos from the MWT were analyzed with MWT-associated 
software to calculate the average forward velocity. Egg-laying assays were 
performed as described by Koelle and Horvitz (1996). In brief, L4 larvae were 
isolated and allowed to develop for 40 hr. Adults were then transferred into 
individual wells of 96-well plates containing 1% sodium hypochlorite and 
incubated until the bodies were dissolved. The number of unlaid eggs 
accumulated inside of adult animals was then counted. 
 
Aldicarb and levamisole assays were performed with young adults. Animals were 
transferred to NGM plates supplemented with 1 mM aldicarb and 200µM 
levamisole respectively. The percentage of paralyzed animals was scored at 15 
min intervals until every assayed animal was paralyzed. Animals were scored as 
paralyzed when they did not move when prodded with a platinum wire.  
 
Microscopy  
Animals were mounted on 2% agarose pads containing 60 mM sodium azide for 
5 minutes before being examined for fluorescent protein expression and 
localization. Images were captured under consistent detector settings with a 
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Hamamatsu Photonics C2400 CCD camera on a Zeiss Axioplan2 Imaging 
System. Images were projected into a single plane using NIH ImageJ software.  
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Table III-1. Forward suppressor screen identifies new alleles of genes 
required for CaV2 trafficking, localization and function. Shown is a list of 
alleles identified in the unc-2(zf35gf) suppressor screens grouped according to 
function. We isolated 29 alleles that were resistant to the effects of aldicarb but 
not resistant to levamisole. Genetic analysis and whole genome sequencing lead 
us to identify 28 of the 29 mutations, all of which occur in genes known to play a 
role in CaV2 trafficking, localization and function. One allele, zf136, still needs to 
be identified.  
  
!
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Figure III-1. Genes required for CaV2 channel trafficking, localization and 
function in synaptic transmission 
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Figure III-2. zf121 is a novel allele of the CaVβ subunit gene ccb-1.  (a) 
Quantification of % animals paralyzed on 1 mM aldicarb over time for indicated 
genotypes. Each data point represents the mean ± SEM of the percentage of 
animals paralyzed by aldicarb every 15 minutes for two trials, totaling a minimum 
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of 30 animals. (b) Gene structure and protein domains of ccb-1. Coding 
sequences are represented as black boxes. The zf121 allele is a single 
nucleotide transition resulting in an isoleucine to threonine (I -> T) amino acid 
substitution at position 84 in the SH3 domain. (c) Expression of the CaVβ/CCB-1. 
GFP::CCB-1 driven by its native promoter is detected in neurons and muscle 
cells of the pharynx (upper panel) and body wall (lower panel). Subcellular 
localization of the GFP::CCB-1 is distributed in both nuclei and cytoplasm. (d) 
GFP::CCB-1 is localized to presynaptic sites and colocalized with the RAB-
3::mCherry vesicle marker in the GABAergic motor neurons in the ventral nerve 
cord (VNC). Asterisk indicates soma and arrows point to the pre-synaptic sites. 
(e) CCB-1 is distributed in both the nuclei and cytoplasm. Single slice of confocal 
images showing that GFP::CCB-1 colocalizes with the NLS::RFP in nuclei along 
the VNC. All images, if not otherwise specified, represent Z projections with 0.3 
µm interval between individual slices and were taken with confocal microscopes. 
Scale bars represent 10 µm.  
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Figure III-3. ccb-1(zf121) mutants are defective in locomotion and egg-
laying behaviors. (a) Average instant forward velocity analysis for the wild type 
(0.10 ± 0.0 wormlength/sec), ccb-1(zf121) (0.05 ± 0.00 wormlength/sec), unc-
2(e55lf) (0.03 ± 0.00 wormlength/sec), egl-19 (n582lf) (0.02 ± 0.00 
wormlength/sec), Pccb-1::CCB-1; ccb-1(zf121) (0.11 ± 0.01 wormlength/sec), 
Prgef-1::CCB-1; ccb-1(zf121) (0.07 ± 0.01 wormlength/sec), Pmyo-3::CCB-1; 
ccb-1(zf121) (0.05 ± 0.00 wormlength/sec). Data obtained from 3 independent 
trials totaling more than 20 animals. (b) Numbers of unlaid eggs in the uterus of 
indicated genotypes. Wild type (17.65 ± 0.68, n=43), unc-2(e55lf) (8.09 ± 1.33, 
n=85), egl-19 (n582lf) (39.14 ± 1.58, n=14), ccb-1(zf121) (31.5 ± 1.52, n=28), 
Pccb-1::CCB-1; ccb-1(zf121) (19.78 ± 0.86, n=36); Prgef-1::CCB-1; ccb-1(zf121) 
(24.42 ± 0.98, n=33); Pmyo-3::CCB-1; ccb-1(zf121) (18.67 ± 1.26, n=12).  Error 
bars represent S.E.M. * represents statistical difference from wild type, * p<0.05, 
****p<0.0001, one way ANOVA with Dunnett’s tests.  
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Figure III-4. ccb-1(zf121) mutants are hypersensitive to the cholinergic 
agonist, levamisole. (a) Quantification % animals paralyzed on 1 mM aldicarb 
over time for indicated genotypes. Each data point represents the mean ± SEM 
of the percentage of animals paralyzed by aldicarb every 15 minutes for at least 
three trials, totaling a minimum of 50 animals. (b) Quantification % animals 
paralyzed on 200 µM levamisole over time for indicated genotypes. Each data 
point represents the mean ± SEM of the percentage of animals paralyzed by 
aldicarb every 15 minutes for at least three trials, totaling a minimum of 50 
animals. 
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Figure III-5. GK domain is essential for the function of CaVβ/CCB-1. (a) 
Schematic of different domain-deleted CCB-1 constructs (b) Representative 
images of the localization of domain-deleted GFP::CCB-1 in young adult animals. 
All images represent Z projections with 0.3 µm interval between individual slices 
and were taken with a spinning scan confocal microscope. Scale bar represents 
10 µm. (c) Average instant velocity for the wild type (0.13 ± 0.01 wormlength/sec, 
n=12), ccb-1(zf121) (0.06 wormlength/sec, n=12), ccb-1(zf121); Pccb-
1::GFP::CCB-1 (0.11 ± 0.01 wormlength/sec, n=11), Pccb-1::GFP::CCB-1(ΔSH3) 
(0.12 wormlength/sec, n=12), Pccb-1::GFP::CCB-1(ΔHOOK) (0.11 
wormlength/sec, n=12) and Pccb-1::GFP::CCB-1(ΔGK) (0.08 ± 0.01 
wormlength/sec, n=12). (d) Numbers of unlaid eggs in the uterus of indicated 
genotypes. Wild type (19.63 ± 1.07, n=24), ccb-1(zf121) (37.75 ± 2.103, n=24), 
ccb-1(zf121); Pccb-1::GFP::CCB-1 (19.88 ± 1.18, n=24), Pccb-1::GFP::CCB-
1(ΔSH3) (26.46 ± 1.15, n=24), Pccb-1::GFP::CCB-1(ΔHOOK) (27.54 ± 1.9, n=24) 
and Pccb-1::GFP::CCB-1(ΔGK) (32.13 ± 1.55, n=24).  Error bars represent 
S.E.M. * represents statistical difference from wild type unless otherwise 
indicated, ** p<0.01, **** p<0.0001, one way ANOVA with Dunnett’s tests.  
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CHAPTER IV 
 
 
 
 
Discussion and Future Directions 
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Most neuronal communications in the brain involve rapid neurotransmission. 
Synaptic transmission is initiated when an action potential arrives presynaptic 
nerve terminals and triggers the opening of presynaptic CaV2 channels. Calcium 
entry into presynaptic active zones then stimulates the synaptic vesicle 
exocytosis (Katz, 1970; Südhof, 2004). Consequently, CaV2 channel activity is 
crucial for precise synaptic transmission, and disruption of normal channel 
activity can be physiologically detrimental. Studies in the nematode 
Caenorhabditis elegans have provided fundamental insights into neural 
development and synaptic function that are highly conserved from worms to 
humans. In this dissertation, I have used C. elegans as a model to show how the 
dysregulation of CaV2 channel activity affects synaptic transmission, circuit 
function and behavioral consequences.  
 
A potential invertebrate model for human FHM1 
Three subtypes of CaV2 channels are encoded by the mammalian 
genome, P/Q-type (CaV2.1 channels), N-type (CaV2.2 channels) and R-type 
(CaV2.3 channels), which are abundantly expressed calcium channel subtypes in 
the central nervous system. Among them, P/Q-type (CaV2.1) have a dominant 
role in controlling neurotransmitter release, partly because of a more efficient 
coupling to the exocytosis machinery (Mintz et al., 1995; Wu et al., 1999). 
Mutations in the human CaV2.1α1 gene, CACNA1A, have been associated with 
several calcium channelopathies such as Familial Hemiplegic Migraine (FHM1), 
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Episodic Ataxia type 2 (EA2) and Spinocerebellar Ataxia type 6 (SCA6) 
(Pietrobon, 2010). While EA2 and SCA6 mutations have been shown to cause a 
reduction in CaV2.1 activity, the effects of FHM1 mutations yield varying results in 
heterologous expression systems with regards to changes in channel expression 
and altered biophysical properties (Cain and Snutch, 2011). FHM1 knockin mice 
have provided the opportunity to study the functional consequences of FHM1 
mutations in physiological relevant conditions and at their endogenous level of 
expression. Studies from cortical neuronal microculture and brain slices of FHM1 
knockin mice suggested these mutations have gain-of-function effects including 
increased Cav2.1 current density in cerebellar neurons and enhanced 
neurotransmission at the neuromuscular junction (Van Den Maagdenberg et al., 
2004; Tottene et al., 2009). However, direct genetic characterization of FHM1 
mutations and molecular mechanisms of how elevated Cav2.1 channel activity 
affects synaptic transmission still need further investigation.  
 In chapter II, I identified a novel allele of the sole C. elegans CaV2α1 
subunit gene, unc-2. This allele contains a Gly to Arg substitution in the highly 
conserved intracellular linker between domain III and IV. While unc-2(lf) mutants 
are sluggish, our unc-2(zf35) mutants display behavioral hyperactivity in 
locomotion and egg-laying behaviors. In addition, direct recording of 
spontaneous release events at the neuromuscular junction showed that unc-
2(zf35) mutants had increased neurotransmission. Electrophysiology recordings 
from HEK cells transfected with the mutant CaV2 channels (G/R) showed a shift 
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in the voltage dependence to more hyperpolarized potentials and increased 
calcium current density, which is similar to CaV2.1 channels with FHM1 
mutations. Identification of intragenic unc-2(lf) suppressors confirmed the zf35 
allele is a gain-of-function allele of unc-2. Excitingly, animals that express unc-2 
transgene carrying corresponding FHM mutations recapitulate both the 
behavioral and pharmacological phenotypes of unc-2(zf35gf) mutants. Our 
results provide strong genetic evidence showing that FHM1 mutations are gain-
of-function mutations of the CaV2.1α1 subunit and an important proof-of-principle 
that the molecular function of UNC-2 and CACANA1A are highly conserved 
from worms to humans.  
 
CaV2(gf) channels leads to an excitation-dominant neurotransmission  
What are the functional consequences of the gain-of-function mutation in 
CaV2α1 subunit at the level of synaptic transmission? unc-2(zf35gf) mutants are 
hypersensitive to the acetylcholine esterase inhibitor, aldicarb, and show an 
increased frequency of endogenous cholinergic mEPSCs. Surprisingly, unc-
2(zf35gf) mutants have a marked reduction of endogenous GABAergic mIPSCs 
resulting in a raised excitation-inhibition ratio. Analysis of synaptic markers 
showed that unc-2(zf35gf) mutants display enlarged pre-synaptic domains in 
both cholinergic and GABAergic neurons, indicating that elevated CaV2 channel 
activity recruits increased numbers of synaptic vesicles to presynaptic release 
sites. However, unc-2(zf35gf) mutants have an increased level of the 
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acetylcholine receptor, UNC-29, at synapses but a significant decrease in the 
level of the GABA receptor, UNC-49. The increased UNC-29 expression is likely 
due to the Hebbian synaptic plasticity in response to the elevated cholinergic 
release. In general, neuronal activity induces a calcium influx into the 
postsynaptic sites. Mammalian literatures have shown that a low calcium level 
leads to a decrease of the number of AMPA receptors, while a high calcium level 
yields an insertion of new ones (Beattie et al., 2000; Fauth and Tetzlaff, 2016; 
Kauer et al., 1988; Mulkey and Malenka, 1992; Shi et al., 1999). On the other 
hand, the reduction in GABA receptor expression is dependent on the 
acetylcholine receptor function, suggesting a crosstalk between excitatory and 
inhibitory receptors at postsynaptic sites.    
Brain function relies on the ability of neural network to maintain its activity 
within a bounded range throughout developmental stages and different 
experiences. Altered excitability of the network has been associated with many 
neurodevelopment and neuropsychiatric disorders, such as epilepsy, Rett 
syndrome and autism spectrum disorder. While most studies have focused on 
mechanisms regulating excitatory or inhibitory transmission independently, a 
growing body of literature has suggested the possibility of crosstalk between 
excitatory and inhibitory signaling pathways (Bannai et al., 2015; Hirono et al., 
2001; Wang and Maffei, 2014). This is particularly relevant for circuits that have 
excitatory and inhibitory synapses that occupy overlapping postsynaptic targets 
(Chiu et al., 2013; Miller, 1996). My data support this model, illustrating crosstalk 
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between excitatory and inhibitory neurotransmission and showed a functional 
interaction between excitatory and inhibitory receptors in postsynaptic cells. 
Enhanced excitatory synaptic activity has been reported to decrease the cluster 
size of GABAARs through NMDA receptor-dependent calcium influx and 
calcineurin dephosphorylation (Bannai et al., 2009, 2015). Investigating if the 
activation of nicotinic acetylcholine receptors, increased calcium influx in muscle 
cells or simply the expression level of the nicotinic acetylcholine receptors are 
required for the reduction of GABA receptor clustering in unc-2(zf35gf) mutants 
will be important to understand this crosstalk. Elevated excitatory transmission at 
cortical synapses has also been reported in FHM1 knockin mice (Tottene et al., 
2009). The enhanced glutamate release contributes to the cortical spreading 
depression (CSD) facilitation, a key player in the pathogenesis of migraine 
(Vecchia and Pietrobon, 2012). Therefore, deeper understanding of the 
underlying molecular signaling pathways contributing to reduction in GABA 
receptors in unc-2(zf35gf) mutants may lead to the identification of new targets 
for therapeutic interventions.  
 
Molecular machinery regulating CaV2 function  
Presynaptic CaV2 channels are crucial regulators for many biophysical 
processes in the nervous system, from calcium-dependent gene expression, 
synaptic transmission to the activation of various calcium-dependent enzymes 
(Simms and Zamponi, 2014). Thus, understanding regulatory mechanisms 
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modulating CaV2 channel function is of profound importance in neuroscience. 
Forward genetic screens in C. elegans have been instrumental in the 
identification of new and highly conserved genes that regulate fundamental 
processes, such as programmed cell death and neural transmission (Ellis and 
Horvitz, 1986; Horvitz and Sulston, 1980; Miller et al., 1996). Unbiased genetic 
screens for suppressors of gain-of-function mutants (e.g. in apoptosis and Ras 
signaling) have been particularly important to unravel unsuspected components 
in these pathways (Hengartner et al., 1992), providing a tremendous drive for 
advancements in the field. Our identification of a unique gain-of-function mutation 
in CaV2α1/UNC-2 opens up an exciting opportunity to powerfully elucidate 
regulatory mechanisms underlying Cav2 channel function, modulation and 
localization in vivo.  
 In chapter III, I performed a genetic screen to identify CaV2 channel 
signaling components. unc-2(zf35gf) mutants are hypersensitive to the 
acetylcholine esterase inhibitor, aldicarb, as this mutation induces enhanced 
choinergic transmission. In this suppressor screen, I searched for mutants that 
are resistant to the paralytic effects of aldicarb in the unc-2(zf35gf) mutant 
background. Secondary screen was performed with levamisole to exclude post-
synaptic mutations. I isolated 29 alleles from the screen in total including new 
alleles of genes that have been implicated in regulating CaV2 channels mediated 
synaptic transmission. For example I isolated alleles of genes that have been 
shown to play a role in in synaptic vesicle release (unc-10, unc-13 and unc-18), 
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calcium channel trafficking and surface expression (calf-1, unc-10, unc-36 and 
ccb-1), and calcium channel auxiliary subunits (unc-36 and ccb-1). These results 
suggested our screening approach was successful in isolating genes required for 
CaV2 channel function. In addition, I recovered three genes that are less 
characterized with their roles in modulating CaV2 channel function: Cav1/egl-19, 
CAPS/unc-31 and a extracellular protein mec-9, as well as one allele that still 
needs to be identified. Uncovering their roles in CaV2 channel function will 
potentially illuminate new mechanisms for regulating calcium dependent synaptic 
transmission.  
 One limitation of this screening approach is that it also pulls out genes that 
function in both pre- and post-synapses. For instance, the Cav11 subunit, egl-
19, which functions in both neurons and muscles (Gao and Zhen, 2011), was 
isolated from the screen and showed levamisole hypersensitivity. In addition, the 
calcium channel auxiliary subunits, unc-36 and ccb-1, which are required for the 
function of both Cav1 and Cav2 channels were also recovered from the screen 
(Catterall, 2011). In these cases, we have to also consider their roles in post-
synaptic muscles. To dissect if these genes suppress the unc-2(zf35gf) mutant 
aldicarb hypersensitivity through pre- or post-synaptic function, neuronal- and 
muscle-specific rescue of these genes are necessary. In addition, further 
investigations on why these suppressors are hypersensitive to levamisole despite 
having defects in muscle Cav1 channels will likely further advance our 
understanding of homeostatic compensation plasticity.   
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In addition to aldicarb hypersensitivity, in the future, using other 
phenotypes of unc-2(zf35gf) mutants may lead to identification of molecules in 
synaptic organization and function in different neuron types. It is less clear how 
synaptic plasticity applies to different classes of neurons. By searching for 
mutants that have reduced reversal frequency in the unc-2(zf35gf) mutant 
background, we may isolate potential regulators for glutamate signaling in 
interneurons controlling directional movements. In addition, looking for mutants 
that have rescued GABA transmission in the unc-2(zf35gf) mutant background 
will shed light on synaptic plasticity during circuit perturbations.  
   
Functional significance of the CaVβ SH3 domain  
CaV2 channels are heteromultimeric membrane complexes that are composed of 
a pore-forming CaVα1 subunit together with auxiliary subunits, CaVα2δ and CaVβ. 
Despite the fact that the CaVα1 subunit determines the major biophysical and 
pharmacological properties of the channel, the auxiliary subunits are 
indispensible and dramatically influence the gating properties and surface 
expression of these channels (Karunasekara et al., 2009). The CaVβ subunit has 
been reported to traffic the CaVα1 subunit from the ER to plasma membrane 
(Bichet et al., 2000) and enhance both the activation and inactivation of CaV2 
channels in an isoform-specific manner (He et al. 2007).  
The ccb-1 gene encodes the putative CaVβ subunit in C. elegans, and 
ccb-1 null allele, ccb-1 (gk18) that contains a large deletion of ccb-1 gene, leads 
! 112!
!
to embryonic lethality, suggesting the importance of the CaVβ subunit function 
(Lainé et al., 2011). In chapter III, I isolated a hypomorphic allele, zf121, of ccb-1 
from the suppressor screen. ccb-1(zf121) mutants are viable with defects in 
locomotion and egg-laying behaviors. The zf121 allele has an isoleucine to 
threonine amino acid substitution in the highly conserved SH3 domain. CaVβ 
subunits share a common structure with a highly conserved core region, 
containing an Src homology 3 (SH3) domain and an enzymatic inactive 
guanylate kinase (GK) like domain, which are connected by a less conserved 
HOOK region (Chen et al. 2004). GK domain has been well demonstrated with its 
importance in the direct interaction with the CaVα1 subunit, and this interaction is 
required for regulating CaVα1 subunit gating properties and surface expression 
(Opatowsky et al., 2004). My in vivo experiments support these findings as ccb-
1(ΔGK) cDNA failed to rescue either ccb-1(zf121) or ccb-1(gk18) mutants.  
On the other hand, the functional significance of SH3 domain and HOOK 
domain remains to be elucidated. Our suppressor ccb-1(zf121) mutants provide a 
line of evidence for the functional interaction between the CaVβ SH3 domain and 
CaV2α1 subunits. The SH3 domain mediates specific protein-protein interactions 
with proline-rich recognition sites, such as PXXP (McPherson, 1999).  In general, 
CaVβ SH3 domain has well conserved sequence and structure consisting of five 
β strands. However, crystallographic studies have shown that the fifth β strand is 
separated by the HOOK domain which creates a “split architecture” for the SH3 
domain of the CaVβ subunit, which might allow CaVβ subunits to have more 
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diverse interacting partners (Karunasekara et al., 2009; Opatowsky et al., 2004; 
Van Petegem et al., 2004). Potential binding partners range from protein kinases, 
GTPase, membrane receptors and ion channels to synaptic proteins (Rima et al., 
2016). Performing pull down assays in transgenic animals carrying GFP-tagged 
wild-type CCB-1, CCB-1(ΔSH3) and CCB-1(zf121) and cross reference the 
interacting proteins will likely identify SH3 domain specific binding partners. 
Further mechanistic investigation on these binding partners will potentially 
provide insight into the roles of the SH3 domain in modulating CaV2 channel 
function.  
  
CaVβ subunits in regulating transcriptional activity 
For many years, the main functions associated with CaVβ subunits are trafficking 
and modulating the gating properties of CaVα1 subunits. However, several 
studies have shown its role in regulating transcription (Hibino et al., 2003; Xu et 
al., 2011), emphasizing the multifunctional role of this versatile protein. The CaVβ 
subunit is the only cytosolic auxiliary subunit of CaV channels and multiple lines of 
evidence have suggested that CaVβ subunits are able to translocate to nuclei in 
an activity and calcium dependent manner (Subramanyam et al., 2009; Tadmouri 
et al., 2012; Taylor et al., 2014). This translocation couples electrical activity to 
gene expression, and defects in this process are associated with juvenile 
epilepsy (Tadmouri et al., 2012). Excitingly, CaVβ function in transcription activity 
is believed to be independent of the GK domain (Hibino et al., 2003), which is 
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consistent with our finding that CaVβ/CCB-1 localizes to the nucleus in a SH3 and 
HOOK domain dependent manner. In addition, preliminary data suggest that 
mutant CaVβ/CCB-1(zf121) subunits, with a isoleucine to threonine mutation in 
the SH3 domain, were also largely excluded from the nucleus. This raised the 
possibility that the zf121 mutation suppresses the gain-of-function CaV2α1 
through a mechanism independent of the CaV2 gating properties.  
With the power of CRISPR technique, I can now label the endogenous 
CaVβ/CCB-1 gene with a fluorescence tag to observe the localization of the 
endogenous CCB-1 in vivo and avoid overexpression effects (Paix et al., 2015). 
Optogenetic manipulation of neuronal activity provides a way to precisely deliver 
the stimulation to specific neuron subsets (Leifer et al., 2011). Together, I will be 
able to examine if the CCB-1 localization is neuronal activity dependent in living 
animals. ccb-1 cDNA does not contain any conventional nuclear localization 
signal (NLS) sequences, suggesting the nuclear localization of CCB-1 require at 
least one protein partner. I showed that this nuclear localization is SH3 domain 
dependent. Thus, the identification of specific binding partners of the SH3 
domain will provide potential gene candidates that are required for this process. 
Lastly, comparing the RNA seq profiling between the transgenic strains carrying 
wild-type CCB-1 and CCB-1(ΔSH3) will offer promising gene candidates that are 
regulated transcriptionally regulated by the CaVβ subunits.   
 Calcium is one of the most important second messengers in neurons and 
plays a key role in various cell signaling pathways. Calcium entry into neurons 
! 115!
!
occurs mainly via presynaptic CaV2 channels, therefore, understanding the 
functional consequences of CaV2 dysfunction and determining the functional 
interacting proteins of CaV2 channels is crucial to comprehend the regulation of 
these physiological events. My doctoral thesis work has shown gain-of-function 
CaV2 channels result in increased calcium influx and synaptic release. At the 
neural circuit level, elevated CaV2 channel activity leads to an imbalance 
between excitatory and inhibitory neurotransmission, which has been implicated 
in several neurological disorders. Suppressors from the genetic screen have 
provided new potential modulators of CaV2 channels as well as a novel pathway 
for CaVβ subunit function. Together, the work has provided new insights into the 
pivotal role of CaV2 channel activity in the integration of neural circuits and lays 
the groundwork for future investigators to explore the regulation of CaV2 
channels at molecular, cellular and circuit levels.   
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